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ABSTRACT 
Althoush a large amount of work has been reported in the 
literature on the effeets of insulin Oft protein biosynthesis. 
very little attention has b.en paid to the corresponding effects 
of the oral hypoglycemic agents. Since these compounds are 
widely used in the control of certain types of diabet.s. it w.s 
considered worthwhile to investiaate their effect on protein 
biosynthesis. and incidentally. to evaluate their efficacy in 
the control of the entire diabetic state. 
The measurement of protein synthe.is used was t:he incorpor-
ation of leucine-C14 into hepatic protein. using a rat liver 
micro.omal system. The.Hl n~Ei addition of any of three agents 
(tolbutamide. chlorpropamide, or phenethylbiguanide) was Observed 
to inhibit the incorporation of leucine.C14 into the protein of 
normal rat liver. This inhibition was in all ca.e. directly 
proportional to the _ount of asent added. over the range in-
ve.tigated. When the liver microsome. from alloxan-diabetic 
animals were employed. the control incorporation was so low that 
it was difficult to observe an inhibition. 
Other experiments on this J.a nIt' effect of the oral hypo-
glycemic agents demonstrated that it was observed when the 
isotope. lysine-C14 and phenylalanine.c14 ware employed in place 
of leucine-C14. It was further noted that the incorporation of 
the isotope into both soluble and microsomal bound protein was 
ii 
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inhibited by the compounds to the same extent. 
Studies on the in ~t[O site of aetion indicate that botb 
tolbutamide and phenethylbiguanide inhibit protein synthesis 
somewhere at the microsomal level, but not at the final step 
where the protein is released from the ribosome. 
Other experimen.ts were performed in which animals were in-
jected with the agents and the ability of their livers to incor-
porate leucine-C14 into protein in vit;[o was compared with that 
of control an~ls injected with an equtmolar amount of aaline. 
A significant decrease in the ability of an antmal's liver 
microsome. to incorporate the isotope into protein was observed 
following the injection of 0.35 m moles tolbutamide or 0.10 m 
moles phenethylbi&uanide. The continued daily injection (for a 
period of four to 8iSht days) of amaller amounts of either agent 
were without siin1ficant .ftect. 
These results are exactly opposite those reported for in-
sulin. Whereas tolbutamide and phen.thylbl~uanid. inhibit pro-
tein synthesis in vitro, insulin acceleratea it. This 8U8&eats 
that the oral hypoglycemic _sent. studied, although very pro-
ficient at lowering blood a,luco •• t do not possess all the other 
attributes of insulin. They cannot, of themselves, aid the 
negative protein balanee associated with diabetes; they may. in 
faet, due to their inhibitory effeets. agaravat. the condition. 
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1 
m HECHAN SM .Qf. PROTEIN rnOSYNTHESIS 
The classical scheme for the biosynthesis of protein by 
the living cell might be described by a .erie. of five steps. 
1. Activation 
A.A. + ATP + Enz. --~. Enz-ANP-A.A. 
II. Transfer of A.A. to s-RNA 
Ill. Attraction of Various Amino Acids to Ribosomal 
Template 
s-RNA-~\A + "Ribosomal RNA TemplateU 
1 
Ribosomal RNA --- (s-RNA-AA)n 
IV. roanation of Peptide Bonds 
n(s-RNA-AA) -......,. (A.A)n + It .-RNA 
V. aelea.e of the Ribosomal Bound Protein into the 
cytoplasmic sap. 
This scheme represents one method of visualizing the process 
but is not intended to be taken .s literally true. Recent 
evidence has sreatly elaboratad upon it and consequently mod-
ified it to a considerable extent. For example, it is highly 
doubtful that steps IV and V occur independently of each other, 
but there is no reason why we cannot think of them in that way 
in order to better visualize the process. With this general 
mechanism in mind, then, let us investigate the process in more 
__ 00 _______ ~_.rll' .. _ .... l a .............................. _ ....................... ___ 011. __ ~_! __ , __ 
-2-
detail. 
Ac;tivation of the Amino Acids 
The use of radioactive amino acids containing the isotope 
carbon-14. had been generally used about 1945-50 to demonstrate 
that living cells can take up amino aeids from thei.r nutrient 
medium and build these into proteins. Ruptured eells, pre-
viously disintegrated under certain mild conditions. retained 
this ability (119). It soon became obvious to the investigators 
that such cell-free systems were dependent upon a supply of 
ATP. Thus inhibitors of ATP formation in cell mitoehondria 
sueh .s anerobiosis, ars.nite. and 2.4-dinitrophenol prevented 
the uptake of amino acids into protein in many systems (10). 
This absolute requirement for ATP has been verified in hun-
dreds of laboratories using isolated mierosome. and cell sap 
for the incorporating system. 
The ATP requirement described strongly suggested that the 
activation of amino acids required a reaction with this substanc. 
The first proof. of this postulate came in 1955 involving 
systems in supernatant fractions fram animal tissues (39) and 
microbial cells (24). Both of these reports described an ex-
ehange reaction between labeled inorganic pyrophosphate (pp32) 
and ATP which required the participation of amino acids. The 
follOwing equilibrium reaction was suggested: 
AA + ATp32 , ....), AA-AMP + pp32 
~----------------------------------"------------------------------~ 
,....... __________ ......... --=-~---' ... ,_. __ .... "' ....... ___ 1 ___ !S!O~'?>'~~' __ .., 
It was further observed (39) that adding a large excess of one 
amino acid does not prevent an additional pp32.exChange upon 
the addition of another amino acid. This early observation 
indicated that each amino acid has its own corresponding 
activating enzyme so that no competition exists for binding 
site •• 
Direct evidence for the role of ATP in forming an activated 
amino acid adenylate complex was demonstrated in 1958 by 
Karasek .IS. !!. (46) and by Kingdon .t.I .!.! (48). These workers 
isolated large amounts of purified tryptophane activating enzyme 
(15 - 50 ag) and used this to form the corresponding adenylate, 
one molecule per molecule of enzyme. The product was rel.sed 
by denaturation of the enzyme with acid and was shown to be 
identical with synthetic tryptophane adenylate in chromatographic 
and electrophoretic behavior, .s well as in cas. of breakdown 
by hydroxylamine and water. The structure of an amino acid 
adenylate (AA-AMP) is given in Fisure 1. 
The enzyme. required for the activation have been studied 
in some detail. ATP is the only nucleoside triphosphate used 
for the activation of the amino acids, so the binding sites must 
be specific for the purine base adenine (39). MagneSium ions 
are necessary for activity, but their function remains obscure; 
in some systems pota.sium ion is also required (4). Chemicals 
which react with free sulfhydryl group., such a. p-chloromercuri-
benzoate, can cauae 108s of activity (20). It is interesting to 
~--.......... ----------------------------------,----------------------~ 
.--_____________ ".................... 111 •• _..... 1 .... l1rm ____ 1III!UII~j __ IMIt_,!S'l"'''''' ____ ._ma;: _. _ 
NUZ 
\ 
R varies with the Amino Acid 
Figure I 
An Amino Acid Adenylate 
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note that these enzymes are not absolutely specific. For example, 
the isoleucine-activating enzyme from ~-Col~ can a180 cause the 
activation of valine, a1t:hough at: a slower rate (7). Con-
versely, valine activation by the valine-activating enzyme 1s 
inhibited by isoleucine (63). Obviously, the ability of E-~2ti 
to incorporate a specific amino acid lnto a giverl protein does 
not: reside solely in the speciflcity of the activating enzyme. 
A;;asmmt o( MiDo Agid, ;2 '-W 
The amino acidad.nylat .... nzym. complex reacts with a 
lpacific s-RNA molecule to form the amino acyl-s-RNA complex. 
The activating enzyme 1s liberated to be used again and AMP is 
also formed. For each amino acid there app.ars to be at l •• st 
one .pecific a-RNA molecule pre.ent. The amino acid 1s attached 
by it. carboxyl group, forming an •• ter linkage to either the 
2' or the 3' hydroxyl group of the ribo.e in the terminal 
adeno.ine group of the .-RNA molecrule (95). It is not clear in 
which form, 21 or 3', 'the amino~cyl a-RNA is first made or in 
whicb form it is utill.zed; and, 1.n fact, the qu •• tion may be 
meani1l81 •••• ince r.cent work. bAs .hown that the amlno acyl 
group l.In:erchang •• rapidly between th •• e two posslble positlona 
(75) • 
In the pr.senc. of ATP and an exee •• of activating enzyme, 
a preparation of unfraetionated .-RNA may be saturated to a 
definlte level with lncr ... lng amounts of an amino acid. Fur-
~-------------------------------,~~-------,----------------------~ 
ther additions of this amino acid do not increase the amount of 
label attached to the a-RNA. On the other '-1&nd, if now a 
second amino acid 1s added, it will be taken up and attaChed to 
its specific a-RNA moleeule. in the preparation (5). 
The proof that the amino acid i. covalently bonded to tbe 
s-RJ."1A has been provided by the action of panereatie ribonuclea.se 
upon a radioactively labeled amino acyl-saRNA. Thts enzyme 
det;rades the s-RNA with the liberation of the terminal adenosine 
moiety to which the radioactive amino acid is .till attaehed. 
This amino acyl-adenosine compound was isolated by electrophor-
esis and chromatography and compared with the synthetic ea.-
pound. Its structure vas further verified by degradation to 
adenosine and the amino acld (118). 
StEYs¥yre 2f s-RNA 
Normal preparations of s-RNA from miera-organisms or from 
mammalian liver have a number of eharaeteristies in cOt'lb'non (109). 
All have approximately the .am~ molecular weight (about 25,000) 
corre.ponding to a total of 75 - 80 nucleotides. These are 
arranged in a single chain at one end of which i8 a fre. 51 
phosphate group attached to a terminal guanylic acid residue. 
The other end of the chain (the site of attachment of the 
amino aeid) invariable terminate. in the .equenee cytosine-
cytosine-adenine. It i8 believed that the nucleotide sequence 
in the interior of the chain varie. with the different amino 
acid-specific: a-RNA molecules. 
In solution a-RNA shows hyperchromicity (an increase in 
absorba.nce upon heating) '-Ihich supports the idea of c:ons:lder-
able base pairing in the molecule (96). Because this hyper-
chromicity on heatin~ i8 completely and rapidly reversible. it 
has been assumed that the native molecule is fonned from a 
single nucleotide chain bent back upon ltself. leaving one or 
more loops in the structure. Poasibly 1t 1s the looped part of 
the molecule with exposed nueleotide bases which recognizes the 
nueleotide sequence of the m-RNA when the a-RNA aligns itself 
on the template. Canton! (15) postulated that it is this loop 
in the structure of the a-RNA molecule that contains the base 
sequence complementary to the eo(U.n& triplet of the m-RNA; he 
has called this the Noo22. because lt is complementary to the 
!(OPON. the current name for the coc:U.ng unit. 
There are theoretlcally four speclal altes on the s-RNA 
molecule Whlch might be discus.ed. 
1. AMINO ACID ATTACfD(DlT 6,i:fi. This i8 found at one end 
of the chain bearing the ter,minal sequence cytosine. 
cytosine-adenine and appears to be the 8ame for all types 
of a-RNA. 
2. ACTIVATING ENZl)tE RECOGNITION SITE. There must be a 
site which recognize. the specific amino acid activating 
eftz,.e so that only the proper amino acid would be bound 
by an individual s-RNA.. In other words. there must be a h-_______________________________ ,________________________________ ~ 
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site on the leucine specific a-RNA which would attract 
only the ENZ-AMP-Leu complex. The location on the mole-
cule of auch a site is st111 obscure. 
3. CODING RECOGNITION SITE. This is the so called Nonce 
which is specific for one type of a-RNA and hence specific 
for one particular amino acid. Thia site is responsible 
for recognizing the triplet code on the template thereby 
arranging the individual amino acids into their proper 
order. It is likely that this site is found at the loop 
of the s-RNA structure where the bases are exposed (not 
paired). 
4. RI80SOME BINDING SITE. It might be necessary for the 
s-RNA molecule to bind to the ribosome to ensure a 
.ufficiently long time of positioning of the amino acyl-
a-RNA on the template. The existence of this last site is 
open to question since the attachment of the a-RNA to the 
template may be 'simply by base pairing of the NODOC with 
the CODON. 
It is believed that the nucleotide sequence of the a-RNA 
molecule is formed by the DNA-dependent enzyme, RNA polymerase, 
which transcribes some portion of the DNA molecule in the 
nucleus (98). This enzyme probably synthesizes the entire s-RNA 
molecule with the exception of the invarient cytosine-cytosine-
adenine terminal residues. These have been shown to be added 
to the molecule by a separate enzyme isolated from the 100,000 
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& supernatant (6). It appears .s though the RNA polymerase makes 
a nucleotide chain without the last three nucleotide. and that 
these are then attached in their correct sequence by the tel'· 
minal-adding enzyme using C'f? and ATP. 
To clarify this procedure, it mig,nt be well to review 
briefly some nucleic acid biochemistry. DNA consists of four 
bas~es: adenine, guanine. cytosine, and thymine. RI'1A contains 
the first three base., but uracil i8 substituted for thymine in 
all eases. The bases are complementary to each other, so that 
adenine will be attracted to uracil (or thymine) while guanine 
will be attraeted to cytosine. The basis for such attract10ns 
is the formation of hydrogen bonds between the moleculea (109). 
Hence the following relationships exist. 
DNA A 
- G - C - A - A - T 
m-RNA U 
- C - G - U 
- U - A 
s-RNA t-G_-J\-~-J 
a-RNA a-aNA 
DNA having the partial sequence described will form m-RUA 
which is complementary tu it as illustrated in the d1ae,ram. 
Each triplet of Bas/!}s in the m-RNA will, in turn, attract an 
.-R~\ molecule having 3 fre. bases which are complementary eo 
it. Thus the indiy1.dul!I..l amino acids (which. are attached to the 
s-RNA) are lined up tn their proper sequence. 
§TRUCTUnB OF RXBOSONES 
-10-
removal of larger particles. by precipitation at pH 5 and 
chromatography on ion exchange columns. In i-Galt t the ribo-
somes contain 60 per cent protein by weight and 40 per cent 
RNA; their stability was found to be dependent on the magnesium 
ion concentration (107). A number of ribosomal subunits were 
discovered in E-Coli, differing greatly in molecular weight 
(and hence in their sedimentation constants). In a fairly high 
magnesium concentration (1 mM) 70S and 100S ribosomes are .een 
6 
with molecular weights of 2.8 and 5.9 x 10 ,respectively. If 
tbe magne.ium concentration 1s lowered to 0.1 aM however, these 
ribosomes disaggregate forming a mixture of 30s and 50S ribo-
some. with molecular weights 0.85 and 1.8 x 106 respectively. 
This disaggregation 1s reversible, and if the magnesium ion 
concentration is restored to 1 aM, the higher moleeular weight 
ribosomes (70S and 100S) are again evidenced. 
The structure of these ribosomal particles bas not been 
elucidated much beyond this point. As yet no definite function 
bas been established for either the ribosomal RNA or the ribos-
omal protein, other than simply a .tructural one. 
CODING SP:;;CIFICITY OF s-RlY\ 
In 1961 an experiment was performed which demonstrated that 
the a-RNA from one species may be used to synthesize a protein 
typical of a different species (104). Purified ribosomes and 
polysomes were isolated from the retieulocytes of rabbits. 
~--------------------------------------------------------------~ 
~------------------------------------------'--------------------
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These, presumably containing the m-RNA for rabbit hemoglobin 
were incubated with charged s-RNA from E-Coli. This amino aeyl. 
a-RNA from i-CpU. contained all the amino acids required for 
the synthesis of hemoglobin of Which only leucine was radio-
active with C14• It was discovered that the radioactivity was 
incorporated into soluble rabbit hemoglobin in this system. The 
radioactive nm4ly-synthesized hemoglobin ~~s shown to be the 
same as normal rabbit hemoglobin by means of tryptic digestion 
followed by "tin.serprinting" ot the resultant peptides. 
This expertment proved that, in the presence of rabbit 
m-RNA in ribosome. and polysom.. and ot i-~9li a-RNA, the amino 
acids were inserted into their correct positions in the peptide 
chain. Henee it was deduoed that the information for making 
the protein was to be found in the polysome fraction rather than 
in the a-RNA. 
Another insenious experiment has demonstrated that the 
placement of a given amino acid on the template is directed by 
the specificity of the a-RNA and not by the amino acid itaelf 
(17). In this ea.e, § ... Cgll a-RNA was charged with cysteine-Cl4• 
At this point. the cysteine-Cl4 is linked with the a-RNA 
specifie for cysteine. By ehemical reduction with Raney nickel. 
the cysteine was converted to alanine td thout breaking the 
linkage between the amino aeid and the a-RNA. Using a cell-free 
system, it was demonstrated that this alanine-CI4 was incorpor-
ated into protein by synthetic polyribonucleotides that contained 
~------------------------------------.-,----------------------------~ 
-12-
the triplets necessary for cysteine incorporation. Furthermore, 
the alanyl_C14.s.RNAcy's. was not incorporated into protein by 
polyribonucleotidel that did have the coding properties for 
alanine. In short, the amino acid goes where the s-RNA directs. 
tliSSENGER - RNA FORMATION 
The first hint of the existence of a me •• anser RNA - a 
template for protein synthesis distinct from the bulk RNA of 
the Ribosomes - is found in an observation by Hershey (38). 
After a bacterium was infected by a phage, net RNA Iynthesis 
ceased, but a small RNA fraction was seen to turn over rapidly. 
Shortly after this. Volkin and Astrachon (103) showed that once 
a bacterium is infected with a bacteriophage, the syntheSis of 
normal bacterial RNA and proteins ceases, but that after a 
short lag period, the syntheSiS of bacteriophage ... specific 
proteins begins. During the lag period some Rt~ is rapidly 
synthesized with a base composition similar to the phage DNA 
but totally unlike the bacterial DNA. This 1s presumedly the 
new messenger RNA directed by the DNA of the infecting bacterio-
phage and required for the synthesis of the bacteriophage 
proteins. 
A clear demonstration of the formation of messenger RNA 
was performed by Brenner, Jacob, and Me.elson (12). Bacteria 
were grown in a medium containing the heavy isotopes of carbon 
and nitro&en (ie. ell and N1S). At the time of infection of 
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the bacteria with the phaae, a pulse of radioactive phosphate 
was given and the bacteria transferred to a medium containing 
the normal lighter isotopes of C'!rbon and nitrogen; bence all 
new cell components made after phage infection were made with 
a light isotope. The cells were then broken open and the extract 
was put in an ultracentrifuge into a gradient of cesium chloride 
to .eparate the different components. In this way. it was 
possible to distinguish ribosomes made before phas,e infection 
(heavy) from those made after phage infection (light). In 
addition. the new m-RNA made after the phage infection. was 
characterized by bein& radioactive with p32. From the position 
of the ,32 labeled new mesaen&er FAA in the gradient. it was 
evident that the newly synthesized m-RNA formed after phage in-
fection was associated with the old ribosomes. This indicates 
that the m-RNA, after being. formed on the DNA, becomes asso-
c1ated with preexisting ribosomes to form the active polysome 
complex. 
Oras, Watson, and their colleagues demonstrated the form-
ation of m-RNA in uninfected baeteria (3S) (36)., They exposed 
cultures of E. C21~ Which had been starved of uraCil, to a 30 
14 
seeond supply of C -uracil, followed by varying times of ex-
posure to C12.uraeil. They then looked for the appearance of 
this F.NA-speeific label in the eell extracts, separating the 
various components in a suerose gradient ultracentr1fugation. 
The radioactivity measurements ahowed a rapidly labeled peak in 
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a region between the a-RNA and the 30S ribosome peaks. Thi. 
peak of radioactivity represents the newly formed m-RNA. 
In a second part of the experi.ent. the bacteria that bad 
been exposed to the short pulse of C14-uracil were incubated 
with unlabeled uracil lonS enough for the m-RNA to decay (20 
minutes). The radioactivity pattern now follows the contours 
of the 30s and 50S ribosomal peaks. indicatina that the m-RNA 
bas been degraded and the radioactivity incorporated il\to ribOS-
omal RNA. 
Thi. instabiU.ty of the maRNA I.a more characteristic of 
baoterial syat .. s than of some mammalian systems. It has been 
shown. for example. that the m-RNA of reticulocytes 1s stable 
over a coosideral) 1e period of time (71). However t before 
Buccessful generaliti •• may be ma.de. it will be neces.ary to 
study them-iNA of many more type. of mamma 11al\ systems. 
$IRVCTUR&; OF POLYRIBOSQ'M;:S 
It was observed that the ribosome fractions most active in 
protein synthesis in ~I ~0f.i were th.ose witn a sedimentation 
constant higher than 70S (89) (101). It appeared from this that 
certain claise. of heavy ribosome. were perhaps the primary site 
of prote1n synthesis, with the sm.aller ribosomes being degrada-
tion products of the larger aggregates. 
The most convincing dem.on;:;t:ration of the existence of poly-
some. came from an examination of the molecular size of the 
-1S. 
active ribosomes that synthesize hemoglobin in rabbit reticulo-
cytes (30) (72) (106). When the cells a.re broken by drastic 
methods, ultracentrifugation in a sucrose gradient shows mainly 
ribosomes with a sedimentation constant of 76S. These have a 
6 
molecular weight of approximately 4 x 10 and a.re referred to as 
usin&la ribosomesn or monoribosomes. i;.!'ben the reticulocytes 
are incubated with radioactive amino acids before lysis, the 
radioactivity is associated with the 76S particles or mODoribo-
some.. There is also radioactivity present in the soluble 
hemoglobin. but this has a much lower sedimentation constant of 
approximately 45. The.. same purified monoriboaomes may be 
used to incorporate radioactive amino acids into protein, but 
the amount of soluble hemoalobln that can be made is very small. 
If. on the other hand, the reticulocyte. after incubation 
with radloactive amino acids are lysed very gently by lowering 
the ionic strength, the sedimentation pattern contains a heavier 
peak with a sedimentation constant of 1703 in addition to the 
768 peak of the monoribosom.s. Even more significant is the 
fact that the radioactivity (which 1s pre.uraedly associated 
with newly formed protein) ie found almost exclusively in this 
heavier ribOlcaull peak.. There is allo a peak of radioactivity 
in the 45 fraction which corr •• ponds to soluble hemoglobin. 
The •• active heavy ribosomes have been named polysomes and 
calculations from their sedimentation conatanta indicate that 
they contain an average of five 76S particles each. 
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Electron microscopic examination of this 170 S peak showed 
clusters of ribosomal particle. whereas a stmilar examination 
of the 768 peak showed almost exclusively single particl.s (106). 
The average number of monoribosomes per polyribosome was five, 
with fewer clusters of four and six. Preparations of such 
polysome. stained for RNA with uranyl acetate show very thin 
threads between the ribosome particles on the polysome. It seems 
likely that these threads correspond to the mes.enger RNA on 
which the five single ribosome particles are aligned. 
A mode of action of the polysome in protein synthesis has 
been proposed by Warner, Knopf, and Rich (105). Single ribosomes 
are supposed to move alona the length of the m-RNA, synthesizing 
a polypeptide chain as they progress. When they reach the end 
of the m-RNA (i.e. the end of the polysome), they falloff and 
release the newly formed peptide chain. As one ribosome leaves 
at one end of the m-RNA, a new empty ribosome is supposed to 
attach itself at the other end to besin its travel along the 
template. Simple variations of thil scheme have been sussested 
to account for the formation of protein dimers which. are found 
in many proteins such as hemoglobin. This mechanism of action 
should be taken al conjecture or as a plausible hypothesis. 
rather tban as an absolute mechanism since there is no compelling 
evidence. 
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ASSEMBLY OF A PEPTIDE CHAIN 
The question of whether a protein is synthesized in a 
linear fashion from one end to the other or whether it might 
grow from the middle outwardS \".s investigated by Dintzi8 (25) 
(81). For his studies, he used a system of rabbit reticulo-
cytes, since the only protein synthesized there in quantity is 
hemoglobin. He began by assuming that at any point in time, 
there are a large number of hemoglobin chains in varying degrees 
of completion in the biosynthetic process. In a short incuba-
tion with tritiated leUCine, only those chains which were near 
completion would be completed and released as soluble hemoglobin. 
Further, the position of the leueine-a3 would indicate the por-
tion of the chain which was completed last. ~ means of tryptic 
hydrolysis of the pulse labeled hemoglobin. Dintzis found 
that only the four peptides near the carboxyl end of the chain 
were significantly radioactive. This and several other experi-
ments employing longer incubation times led to the conclusion 
that the hemoglobln chain grows in a linear fashion beginning 
at the N-terminus.. This same conclusion ,,,as reached for hemo-
globin synthesis by Bishop, Leaby. and Sehweet (8) and for 
bacterial amylase by Yoshida and Tobita (117). The same eon-
elusion has been reached by Anfinsen and Canfield (14) for 
chicken lysozym.e, so the phenomenon appears to be quite general. 
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Pol'i'i"bonucleot1des and the Genetic C04e 
In 1961, Nirenberg and Matthaei nlade the discovery. that 
synthetic polyribonucleot1.des could stimulate the incorporation 
of labeled amino acids into pf:~ptide-l1.ke material in a cell-
free system from E-Col1 (84). In part1.eular. they demonstrated 
that poly U, a high molecular weight polyribonucleotide con-
taining only uracil. stLmulated the incorporation of phenyl-
alanine into a protein-like material. Furthermore. only 
phenylalanine was incorporated to any extent. t~lrenberg also 
showed that the incorporation of phenylalanine required 
phenylalanyl-s-RftA as a necessary intermediate, and in that re-
spect resembled protein synthesis. Fram this result, and 
assuming the validity of a triplet cede, Nirenberg and Matthaei 
deduced that the code for phenylalanine at the m-RNA level 1. 
UUU. 
Similar .xper1men~s have also been carried out in a number 
of mammalian systems prinCipally derived from reticulocyte. 
and mammalian tumor eell. (l08). and in the •• it is also noticed 
that poly U will sttmulate specifically the incorporation of 
phenylalanine into peptide material. 
Through the us. of synthetic copolymers (produced by the 
enzyme polynucleotide phosphorylase) containing different 
proportions of two or more bases. the incorporation of amino 
acids other than phenylalanine bas been investigated in the 
laboratori •• of Nlrenbera (83) and of Ochoa (97). This type 
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of experiment ~ave the cod. letters for a given amino acld, but 
could not g1 ve the seoquel"!.ce of the letters. Henee the code 
for alanine was found to eon~ipt of the three letters CeG but 
they might be in the sequence ~C or Gee just as e.slly. 
More reeently, Nirenberg and I,edar (59) sh014'8d that tri-
nucleotides of known sequenee will <fireet the specific .ttachment 
of particular amino acyl-e-RNA moleaule. to ribosomes. ror 
example. the trinucleotide GUU allowed attaehment of valyl-s-
MA but not of others. FurtherPlOrA t the trinue le()t1de. UGU and 
UUG were not effective. ~rom this experiment, 1t appears that 
th$ sequenee of the cadii'll triplet for valine 1s GUU. In thls 
mannGr, the entire genetic oode is unfoldin~. 
It "liaS discovered by the prevl.OUs experiments that many 
amino aeld8 have more than one ~roup of code letters a.signed 
to them. Thls ls the so-eallad desenaracy of the codlng (18). 
This implies that a m-RNA tampla~e can provide f~r the inaer-
tion of a given amino acid into the peptide chain by more than 
one triplet of 'a8sl. Henee we would deduce the extstence of 
mora than one I-RNA specific for tbat amino acid. It bas been 
shown by eountereurrent distribution methods (32) that s-RNA 
will yield more than one fraetion capable of incorporating the 
amino acid leucine. ThlR supports the eoneept of eodift8 degen-
eracy. but the true 8ignlfleanee of thl. phenomenon remalns 
to be .atabllsbed. 
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Symmap: 
The beginning of this chapter delineated the S steps in 
the so-called clasaical scheme of protein biosynthesis. It 
should be apparent at this pOint that this scheme is not wrong 
in any .ens., but mer.ly over-s1m.plified. The first two steps 
(amino acld activation and transfer to a-RNA) occur exactly as 
written. Recent knowledge hee shed some light on the specifi-
city of the enzymes and of the a-iKA and on the structure of 
the s-MA. But for the moat part, th.s. two steps remain today 
exactly as they are written. 
The greate.t advance. of current theory of protein bio-
synthesis lie in the elucidation and expansion of the third 
step. We now recognize the existence of 30s and 50S riboeome. 
which may associate to form the 70S particle. A number of 70S 
partieles may unite with a strand of m-RNA to form the active 
polyribosome. Current theory also tells us that the short-
lived m-RNA contains the code which directs the amino aCids to 
their proper positions In the protein molecule. Much of this 
cod. has been elucidated by the us. of synthetic polyribonucleo-
tides. Yet in spite of all thia sophistication, the basic 
scheme remains unaltered in seneral outllne. Hany uncertainties 
regardins specific detal1s stl11 remain. and these will be 
subject of much reaearch 1n the year. to come. 
CHAPTER II 
DIA;l§T~S. INSULIN. Mill. PltQIJUN METABOLtStl 
Uilb'kaS And PEotlin M,taboll!! 
Very early experlmenes indicated thae there was a defect 
in protein metabolism aS8eteiated with diabetes. By 1889, von 
Maring and Minkowaki (76) demonstrated that panereaeectomy 
results in an increased excretion of nitrogen during fasting. 
This observation, which was subsequently verified in numerowt 
labor~torie.. led to the COnclusion that pancreatectomy resulted 
in either a decrease in prot.in synthesis or an increase in 
protein oat4'1>oli_. Or perhapa a combination of th.8 two. When 
the work of Levine and coworkers (61) (62) demonstrated that 
insulin affects the permeability of the cell wall to carbohy-
drates, a mechani.sm wa. senerally accepted whlch considered the 
effects on protein synthesis to be secondary to the effects on 
carbohydrate metaboli_. According to this view, carbohydrate 
utiU.zation 1s depressed in the diabetiC anlmal due to lack of 
insulin. and hence protein is catabolized to serve as a source 
of energy for the cell. 'this theory a.sumes that the increased 
nitrogen excretion following pancreatectomy 1s due to an in-
creased catabolism of prote1n (60). 
However. When radioisotop •• were applied to the problem, 
this hypothesis was seen to be an over .... implific.tion. Krahl 
reported (56) that ehe lncorporatlon of glyclna.l_C14 lnto 
glutathione of llvar .llca. wa.,reatly reduced in .evere 
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diabetes, .s was the incorporation of both glycine_l_c14 and 
phenylalanine-3-C14 into the protein fractions of both liver 
and diaphragm. This depression of incorporation of glycine. 
l_C14 into protein remained relatively the same '(men the glycine 
concentration in the incubation medium was increased by a 
factor of 40. Fran this it was concluded that the net decrease 
in glycine-l .. C14 incorporation into protein in diabetes is 
attributable larsely to decreased synthesis. although a limited 
concurrent increase in catabolism cannot be excluded. It was 
later demonstrated (52) that the degree of the defect in pro-
tein synthesis increases in proportion to the duration and 
severity of the diabetes.. Penhos and Krahl (86) showed that 
this was true for animals made diabetic by pancreatectomy as 
",ell as for animals subjected to treatment wt.th alloxan .. 
The precedtnt experiments demonstrate a decrease in the 
incorporation of radioactive amino acids into protein in the 
diabetic animal using tissue slices (liver or diaphragm) as the 
meana of protein synthesis. Korner (SO) showed that the same 
re.ults obtain in a eell free system. He showed that both the 
mitochondria and the microsomes isolated from the livers of 
alloxan-diabetic rats incorporate 1 ••• radioactive amino acid. 
into their protein in :4$[0 than the corresponding subcellular 
particles prepared from the livers of normal rats. 
By a .erie. of cross-over experiments, he demonstrated 
that the impairment in protein Iynthesis caused by diabetes is 
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found at the m.icrosomal level. This was decided in the follow-
ing manner: A group of both normal and alloxan-diabetic rat. 
"..rere sacrificed and the liver microsomoa and cell .ap laolated. 
A •• "ies of incubations was then performed in which four com-
binati.ons of these were tes'ted. 'l'he first &roup cOl'ltained the 
micro.ames and cell sap isolated frotll the noma.l aniJaala. This 
gave 4 control rata of incorporation of the amino acids into 
protein. The second group utilized the microsomea from normal 
rats but the cell sap from alloxan-diabetic animals. Tbis re-
sulted in values of incorporation only sllgiltly lower than 
thoa. obtained for the control. i.tu'u.catin& that the diabetic 
condition affected the eell sap only 8lightly. The third group 
utilized the cell sap from nomal animals but the mi.crosomes 
from alloxan-diabetie ones. Thi. showed a large inhibiticm of 
incorporation, virtually as camplete as was obtained in the 
fourth group which utiliz.,d both the microso.'Ues and cel.l sap 
from diabetic animals. Korner therefore concluded that most 
of the decrease in incorporation of amino acids shown by the 
microsomal system pr.p.nd fr. livers of alloxan-diabetic rats 
is caused by a.lterations in the ability of the Iaierasome. to 
assamble the amino acids into polypeptide chains. But be admits 
that some depress1.n~, effect on the ability of the soluble frae-
tion of the liver to prepare amino acids for: incorporation i. 
also found in alloxan-diabetic rats. 
A similar seri •• of experiments was performed by Robinaon 
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(91) Who concluded that liver microsom •• from .everely diabetiC 
rats incorporate leucine ... l-C14 into protein at a lower rate 
than microsome. from control rats. His data led to the con-
clu.ion that the.e change. oecured specifically in the micro-
somes; there was no difference with respect to ability of 
soluble fractions to activate microsomal incorporation. 
More recently, Rampersad and Wool (90) have demonstrated 
that the incorporation of phenylalanine into protein by isolated 
ribosomes from the he.rt muscle of rats is decre.sed when the 
ribosomes are obtained from alloxan-diabetic animal •• 
Thus it bas been .hown that diabetes caule. an inhibition 
of protein synthe.i. in ti •• ue Ilic.s, in microsomal cell-free 
systems, and in at least Ofte ribosomal system. It has further 
been postulated that this defect in diabetes is to be found at 
the microsomal (or ribolOllUll) level. 
Ih, §fftst, of Inlulin !dmlnlls£,Clon 1n !lV! on fEotein 
Mtta!1!U •• 
There is a wide range of conflicting early reports in the 
literatu.re concerning the effeets of insulin on the growth of 
an1mall. Some of the conclusions are invalid because they 
were performed on fasting animals. There se_s to be complete 
aare_ant that the administration of insulin does not cause 
demonstrable protein anabolism in the fasting animal (9) (29) 
(31) (94). There is conclusive evidence that in the non-
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fasting animal insulin tends to cause protein anabolism .s 
indicated by a positive nitrogen balance (44) (51) (65) (94). 
However, this tendency of inlluU.D to produce a positl'W nitro-
~en balance bas not led to arowth in normal an1mal. (28) (41) 
(42). The elassical experimental results of the influence of 
insulin on protein metabolism have been summarized 1n Table 1, 
modified from. Lukens (65). 
In contrallt, the evidence from radloisotope experiments 
is much more eompellin& than the whole animal experi..ments thus 
far d •• ert.bEtd. In the isotope experlments, an animal is in. 
jeeted with insulin and the ability of it. liver (diaphragm, 
heart etc.) to incorporate amino acids into prote1n is lisr9 
is compared with that of a control animal injected with saline. 
By usinS this technique, Robinson (91) has shown that the 
micrOS0tU8S from the 11vers of normal rats incorporate amino 
acids at a bisber rate after the injection of insulin. S1milarl~ 
Korner (SO) d_Oftltrated that the treatment of alloxan-diabetic 
rats with insulin r.stored towards nOJ:Dl4l th. d.pr •••• d 41>i lity 
of both mitochondria and microsom •• to incorporat. radioactive 
amino acids into protein. This restoration wal .hown to be 
dependent upon the dosage of insulin lnjected. 
TABLE 1 
STUDIES or THE INFLUENCE or INSULIN 
ON PROTEIN METABOLISM 
1. Pancreatectomy results in an increased catabolism of endo-
genous protein .s evideneed by an increased nitrogen 
excretion during f.sting (16). 
Insulin treatment of the aepancreatectomized animal. or of 
th. .. severely d1abet:1c patient prewnt:s this acceleration of 
prot:e1n catabolism (2) (16) (27) (58) (94). 
From ia.lil! stud1es on the disposal of N1S.glycine. there 
is 8ame evidence that: protein synthesis is defective and 
protein breakdown exce.sive in the diabetic animal (40). 
II. Insulin ,iven to nOl."fU.l animals: 
A. Investigators who failed to observe protein anabolism: 
1. No increased growth of rabbits (64). 
2. No effact on fasting nitrogen balance in rats (9). 
3. No effect on growth or nitroljeft excretion of normal 
rats with or without control of diet (31). 
4. No change 1nnitr08_ excretion (43). 
5. No effeet: on 8.;t'owth of rats (28) (41) (42). 
B. 1Dvestisators who concluded that insulin promotes pro-
tein anabolism.: 
2. 
4. 
5. 
Glucos. and insulin spar. more protein than ~luc08. 
alone 1n normal subjects (44). 
Insulin cau ••• positive nitrogen balance in fed 
normal dOg8 (94). 
Insulin cause. nitrogen retention in normal rats. 
with. or without constant d1et (65). 
There i •• een a positive nitrogen balanc.1n pa-
tients given insulin (51). 
Liver and diapl1ragm incorporate more labeled amino 
acid U1.'ld,r influence of insulin if gluco •• is 
present \53). 
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lbi In VLeEt E(f!es- of InluliA URon Is01ated It.aue, 
1. Effect on Muscle 
The rat diaphrap haa been widely used as a represent-
ative mulcle since it eLm be readily isolated and incorporates 
amino acids into its protein, apparently chiefly in peptide 
linkaf)fI (10). 
Sinex .!I !1 (93) and Krahl (56) independently observed in 
1952 that the incorporation of slycine-C14 or alanine_C14 into 
protein of ciiaphrapta from feet rate was enhanced by the 1.n 
ntEo ad~ition of insulin to the incubation medium in the 
ab.enee of added glucose. Manchester and Young (68) demonstrated 
this effeet of insulin upon the incorporation of 9 different 
radioactive amino acids both in the presence and absence of 
added gltlCOS. or pyruvate. They furtber noted that neither 
glucose nor pyruvate alone had any .ffeet upon the incorporation. 
The •• results seamed to indicate that the f1tffect of insulin on 
protein metabolism in this ea •• was independent of it. effect on 
glucose transport. 
Several control experiments were made to exclude glucose 
transport a8 the basis for the insulin effect (115). Diaphra~. 
were thorou~hlY' washed in !lueose-free medium before transfer 
to the final incubation medium; .no free .glueofte eOltld be detected 
by analysis of the wtluthed muscle. Th. dia.phragms were then. in-
cubated for 2 hours at 37°c without glucose or insulin, then 
transferred to a fresh medium with or without insulin and 
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incubated for an additional 2 hours in the presence of a radio-
active amino acid. Insulin atill produced a significant st~­
ulation of incorporation. although any glucose carried over by 
the donor would have benn exhausted in the first 2 hour ineuba-
tion. It was further observed that the addition of large 
amounts of glucos. to the medium did not increase the amino acid 
incorporation by diaphragms from fed Sprague-Dawley rats (115) 
nor by diaphragms of 24 and 48 hour fasted Wistar or hooded 
rats (69) under the same conditions in which insulin alone was 
effective. These experiments are all taken to indicate that 
inlulin can stimulate amino acid incorporation into protein by 
a mechanism which does not depend on glucose transport. 
On the other hand, experiments performed ~4ith fasting 
Sprague-Dawley rats showed a different effect (116). As the 
period of fastin, increased, insulin alone had le81 effect in 
the abaenee of glucos.. When glueos. was added to the medium. 
the incorporation of amino acids was increased marginally, but 
the capacity to r.spond to insulin was fully restored. These 
r.sults were taken to indicate that under certain conditions the 
supply of ener~y or of intermediates from carbohydrate metabolism 
apparently becomes limiting and then the tnaulin affect on 
amino acid incorporation b~eomea dependent on the transport of 
extracellular glucose into the muscle cell. 
In 1960, Wool verified that the inSUlin effect on the in-
corporation of hiatidine-2-C14 into the protein of diaphragm 
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from the 48 bour fasted Sprague-Dawley rat vas directly pro-
portional to the glucose concentration in the range of 0 .. 600 
m&% (114). ae noted, however, that a number of other sugars, 
noteably D-manno •• , D-xyloae, D-ribose, and L-sorbose were a. 
effective as @lucoa.. Since the last three are not utilized by 
diaphragm muscle, be conclude. it is unlikely tbat the positive 
influence of carbohydrate on protein metabolism derives from its 
ability to increase the energy available for protein synthesis. 
Experiments involvins the metabolic fate of these sugars failed 
to show any correlation between their metabolism in diaphragm 
muscle and their ability to restore the iusuli.n effect (112). 
Although it now se .. a likely that the 1D v~~~~ effect of 
insulin on protein synthesis in the rat diaphragm is not a 
.econdary effeet due to a primary effect on glucose transport, 
there is much speculation on the true mechanism of action of 
insulin. The discovery that the transport of ~-aminoisobutyric 
aeid into isolated rat diaphra~ waa increased by the in visro 
addition of inaulin led to the interesting possibility that in-
sulin affected the transport of amino aeid. into the cell in 
mueh the same way as it affecta the transport of glucos. (49). 
Unfortunately, this reasonable explanation was disproved by Akedo 
and Chriatensen (1) who discovered that, althoug,h insulin does 
affect the transport of several nOD utilizable amino aCid., it 
bas no effect on the majori.ty of th.e natural amino acids. 
Further. the inaulin stimulus is still .een when the labeled 
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amino acids are formed intraeellularly from radioaetlve pre-
cursors such as bicarbonate, acetate, citrate etc. (61). 
The most recent' theory proposed tor the protein anabolie 
action of insulin is thFtt it somehOw affeets the formation of 
m-RI'lA, perhaps by eombining with the represlJor gene, maJdng it 
unable to combine with the operator and henee leading to the 
synthesis t)f more m-RNA (113). Tbis particular theory is 
under intensive study in 1"'001.' s laboratory at th4!J present time. 
11. Effect on Liver 
Krahl (52) (55) (56) reported that the capacity of 
liver slice. to incorporate glyeine-C14 into the peptide gluta-
thione or protein was 1mpair~d in liver 811e81 frtlm alloxan-
diabe't'ie rats, the desree of the defect being in direct propor-
tion to the severity of the cU.abet... No direct 1D nt[2 .ff.et 
of insulin could be demonstrated wi't'h alic.s from the mo.t 
severely diabetic animala, 81t11.ou3h restoration of normal incor-
poration could be aebleved by injeetion of insulin and the 
pa •• age of 10 hour. or mor •• 
The situation with liver alia •• from mildly diabetic rats 
was, however, quite different: insulin added .!n vitrg raisftd 
the incorporation of glyeine-C14 into slutath10ne or protein if 
slueo •• was also present; S\luens. alone had a slight .ffect, 
in.ulin alone !lad none.. Th& .... experiments were later repeated 
by fenhol and Krahl (86), u.1ftg liver allee. from both nonal 
and partially depancreatized rats at variOUS times after paner ••.• 
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removal. The r.sults fully confirmed and extended the earlier 
W'Ork in d __ atrating: 
A. that insulin stimulate. amino acid incorporation into 
liver protein when added 1a vilEO 
B. that this effect depends on tbe pre •• nce of ,lucole 
C. that the stimulation is areater with slices fro. mildly 
insulin-delicieat animaL. than with those from either 
normal animals or 10ll& tem diabetic animale. 
D. that this in Yili2 effect of insulin requires 2 - 3 
houri to become maxillal. 
The conclusion derived from this work il that insulin can act 
directly on the liver to stimulate amillo acid incorporation into 
protein by a mecbanism dependent upon the presence of glucal:3e. 
111. Effect on Adipose Tissue 
Labeled amino acids are rapidly incorporated ia 
VitE2 into the protein of rat epididymal adipose ti.sue (37) 
(54). The incorporation of the labeled amino acid into protein 
is enhanced by insulin only wben same carbohydrat. substrat., 
such •• pyruvate or glucose. 1s present in tbe medium. In a 
more recent report (57) it is mentioned that both pyruvate and 
Cluccs. alone stimulate incorpor.tion, but pyruvate plus insulin 
or glucos. plus insulin Sive a significantly treater incorpor-
.tion. fio iner.... in incorporation was noted if insulin vas 
added to the medium in tbe absence of either pyruvate or glucose. 
The mecbanism of the stimulatory effect of insulin upon 
incorporation of amino acids into adipose tissue protein has 
been part!.ally explored. It is evidently not concerned with 
stimulation of glucose transport. sinee it CAn be produced in 
the absence of glucose if pyruvate is present. The insulin 
stimulus is obtainable when the amino aeid is formed intra-
cellularly from a precursor such as pyruvate.C14 and thus does 
not appear to be concerned with the transport of amino acid 
from an extracellular to an intracellular phase (54). It is to 
some degree specific for the incorporation of amino acids into 
protein, as the conversion of pyruvate .. C14 carbon to alanine in 
protein may be stimulated. while the incorporation of the ~:'\;3m. 
carbon into fat of the salDe pieee of tissue is not (54). Hence 
it appears likely that the insulin .:s acting specifically upon 
same process concerned with protein synthesis. 
IV. Effect on Cell.Free System 
If a cell-free system could b. devised in which the in 
vitro addition of insulin would accelerate protein synthesis. 
it would be a great boon to research 1n this area. To date, 
there has been no recorded instance in which insulin added in 
vit[2 has been shown to increase protein synthesis by a cell-free 
microsomal or ribosomal system:. Robinson (91) reported that 
the addition of insulin J:n nt£o to a microsomal system from 
normal rat liver was totally without effect. Manchester (66) 
notes that no such effect bas been found in any broken cell 
preparation. Recently. \-1001 (90) has added insuU.n .1!1 yitEO 
to ribosome. from heart muscle and found that it did not affect 
the ability of the particles to catalyze the incorporation of 
radioactivity fram • lUiA-phenylalanine-c14 into protein, whether 
or not polyuridylic acid was pre.ent. Hi. own words aptly 
describe the situation at the pre.ent tlme. 
-The lack of effect: of the homone when it is added .&a yj.&i9 to 
the cell-free system is a diaappointment. but no alteration of 
the experimental desian or circumstances has yet Changed the 
outcom .... 
The various J.u. nSro effects of insulin upon protein metabolism 
in isolated tissu.. have been summarized in Table II. 
Illl Iff.sts Sf Ill. Qral HDo&lxeEie,~!ntl on r§,ot!itl Smt.b~ 
In the past deeade or 80. a n\J.'lRber of oral hypoglycemic 
compounds have gained prominence .s a substitute for insulin in 
the treatment of certain milder type. of diabetes mellitus. Two 
of the most interesting of th ••• agent., repr •• entin! different 
classes of chemical compounds, are tolbutamide and phenethyl-
biquanide. Whereas the former is thought to exert itll effect by 
stimulating the deficient pancre.e to produce more insulin. the 
latter almost certainly act. by a different tnechani_ (21) .. 
Nonetheless. both of the •• compounds are able to adequa1:ely con-
trol the blood sugar level of mild diabetiCS when administered 
orally.. The chemistry of the oral hypoglycemie agent. haa b.en 
reviewed previou.ly by DeChatelet (21). 
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'tAStE 11 
IN VITRO EFFECTS OF INSULIN UPON ISOl.ATED TISSUES 
I.. }>fusele 
A. Diaphragm. frOln fed rats 
A response to insulin i8 obtained without glucose in 
th~ medium. This cannot be reproduced by the addition 
of exo$enous glucose to the medium. This insulin 
stlrmJlu, to protein synthesis is not aecort'tpanied by 
any stimulus to accumulation of natural L-amino acids 
by the diaphragm. 
B. Diaphragm from fasted rats 
The incorporation of labeled amino acids into protein 
1s lower than in diaphraps from fed animals. In some 
specie. of rat. insulin 1s effective only when glucose 
is added to the medium, but a number of non-utilizable 
sugars co\11d substitute for gluco •• in this regard. 
II. Liver 
In iRolated liver, .s in musele, the incorporation of 
amino acids into protein is reduced after prOduction of 
diabetes in the donor, the reduction becoming greater 
.s the intensity of the diabetes increase.. The iD 
vitro addition of insulin enhance. amino acid incorpor-
ation into proteln, but this effect is dependent on the 
presence of glucos. 1n the medium. The insulin stimu-
lation 1. area,e.t in livers from mildly diabetic rats, 
and cannot be demonstrated after severe diabetes, 
accompanied by weisht 10 •• and ketosis, sets in. 
111. Adipose Tissue 
In isolated rat epididymal adipose tissue. insulin 
alao enhance. the incorporation of amino acids into 
protein. Thi. stimulation cannot be obtained without 
the addition of some oxidizable ~lbstrate such .s glu-
cose to the medium. But the insulin effect is not de-
pendent on glucose transport as it can be obtained when 
pyruvate is aubstituted for 81\1cose. 
Although there has been & ~reat deal of work devoted to 
the influence of insulin on prQtein biosynthesis, the problem 
of the influence of the oral hypoglycemic: agents on protein bio-
synthesis has been lat:'gely ignored. In 1957, Recant and Fischer 
(88) reported an eXl'er1rnr:nt involving the oral administration of 
tolbutamide to rat's for a period of five days. On the final day, 
14 the animal:9 ~erE!' saerifieed and the incorporation of glyetne-C 
ir";o liver slice protein was measured and compared with that of 
normal rats. The authors reported that the ability of the liver 
slices fr<XR the tolbutamide treated animals to incorporate amino 
acids into protein was sig..nificantly greater than that of liver 
sllces derived from normal an1mals. They further noted that a 
single acute i.njection ot tolbutami.<Hi produced no effect. The •• 
results are entirely consistent with the proposed mechanism of 
action of tolbutamide; if tolbutamide acts to increaae the prod-
uction of insulin from the pancreas, then the additional insulin 
present would be expected to have an anabolic effect on protein. 
It a_a likely that Recant and Fischer were actually measuring 
an insulin effeet, rather than a direct effect of tolbutamide. 
A little later, in 19S8, a disquieting note came fram the 
laboratory of Manchester (70). \lnil. investigating the in-
corporation of alanine-C14 into isolated rat diaphrap, he 
noted tbat this incorporatlon i8 depres.ed in the presance of 
either tolbutamide or carbutamide resardl ••• of Whether glucose 
or pyruvate waa prea.nt in the medium. A concentration of 
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tolbutamide of 10 millimolar gave an incorporation which was 
only 9~ of the control level. Since this effect was seen using 
isolated tissue, it is a direct effect of the agent. separate 
from any influence on insulin production. 
Here the matter rested W'ltil 1964 wben Jarrett and Butter· 
field (45) amplified the experiments of Recant. They reported 
that a concentration of tolbutamide of 10.2M depressed the in-
corporation of leucine.C14 into the prot.in of diaphragm from 
nor,mal rats. This eff.ct was marainal at a tolbutamide coneen-
tration of 10-3M and was not •• en at lover concentrations. Th." 
further reported that the catabolism of leucine. as measured by 
014 O2 evolution was similarly depr •••• d by the presence of 
tolbutamide. 
Th ••• results were extended to a liver homogenate .ystem 
by DeChatelet and McDonald (22) who reported that both tolbuta-
mide and phenethylbiquanide depre.sed the incorporation of 
leueine_C14 into hepatic protein independently of the glucose 
concentration. The inhibition s.en by the.e two agents was 
quite different 1n ebaracter and corresponded well with a eon-
commitant inhibition of leucine catabolism. More recent exper-
blents (74) have shown that this inhibition of leucine incor-
poration 1s also evident in a microsomal system derived from the 
livers of normal and alloxan-diabetic rats. Thus it appears 
likely that these oral hypoglyc_ic agents are. in thems.lves. 
inhibitor. of protein biosynthesis and do not mimic the action 
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of insulin 1m thi s reapect. In fac:t t their effeet mir-,ht W'ell 
be c:onsidered to be antagonistie to insulin with regard to 
the biosynthesis of protein. 
CHAPTER III 
r1ATERIAltS ANO l1EJHODS 
Glm§RAL EXPERIMENIAL RROStE:DURJ; 
The experiments described in this di •• ertation may be 
divided into two general eatea0rie.: thoae in which tbe addi-
tions were made to a protein synthe.izing SYltam In USEO and 
tho •• in which a eompound wal injected into an animal .1n .J1!'2 
and its effeot measured ill vj;tiO. The first type of experiment 
was performed in the following manner. 
Ff'.llImale Holtzman rats, fed U &:&:bl£W9 Oft a standard stock 
diet. were saeriflced by decapitation. The livers were removed 
without delay, washed in ice cold buffer, blotted, weighed, and 
homosenlzed in cold tria buffer. The homogenate was centrifuged 
for 15 minute. at 10,SOO r.p.m. to remove nuclei. cell debris, 
and mitochondria. Tbe supernatant solution was carefully 
deeanted and centrifuged at 100,000 r.p.m. to sediment the 
mierosomal fraction. A portion of the cleareell sap was care-
fully siphoned off the microsome pellet by means of a hypodermi.c 
syri.nse, and the remainder of the sap was discarded II The 
microsome. were resuspended in buffer by gentle homogenization 
so that a total volume of 0.4 mI. of homogenate contained the 
microsom •• from one gram of liver. Flasks were incubated at 
37° C, usually for a period of 2 hours. Each incubation flask 
contained 0.40 mI. of microsomal suspension; 0.30 mI. of cell 
sap; 0.30 mi. of premix; and 1.0 u curie of leueine.C14• 
In the earlier experiments 1.1: \<7aS desired to study the 
effect of various cofa.ctor9 upon the inecn."poration of leucine.C14 
into hepatic protein. Accordingly, the cofactor under stu.dy was 
omitted from the premix and adde('! separately in the desired 
concentration to each flask. Later experiments were concerned 
with the effects of various oral hypo&lyeemic agents on this 
incorporation. In these cases, the complete premix was used and 
the various additions made separately to each flask. 
The other series of experiments involved injecting an in-
tact animal with a dose of the agent under study. Aftor a 
specified period of time the animal was sacrificed, its liver 
removed, and the same incubation procedure utilized a.a before. 
These ex:per1menta involved both the effect of a single large 
injection of agent and of a smaller daily injection over a period 
of time. Control values ".tere obtained bytha injection into 
other rats of an equimolar amount of sodium chloride. It wall 
necessary to employ litter-}uates for maximum reprGduceability 
in the •• expertBents. 
Adenosine.S'-triphosphate, elisodium salt, Sigma. grade. Sigma 
Chemical Co., St. 1..oui8, Mo. lot I 14B-1090 
Alloxan, monohydrate. Eastman Kodak Co.. ROChester. N.Y. lot 
41 1722 
Cas.1n hydrolysate, acid. Nutritional Biochemicals Corp., 
Cleveland Ohio. lot II 8809 
Chlorpropamide. sodium salt:. Charles Pfizer and Co. Inc.. New 
'lorl(.. N.Y. lot 11 03-422-02EFD 
Cr$4tine phosphate, disodiurn salt. A ired •• Calb1.ochem. Loa 
Ang. les, Calif. lot·jj 60147 
Creatine phosphokinase, A ~rade. Assay 20 E.U.'mg_ protein. 
Calbiocn.m. Los Angel •• , Calif. lot I 53714 
Clueos., C.F. Malllnkrodt Chemloal Works, New York, N.Y. lot 
, 4908 
Glucostat, Worthin&ton Biochemical Cot:p., Freehold, N.J. 
lot # 1015 
Guano.tn. triphosphate, tri.sodlUUl Mlt, A-grade, Calblochem, 
LOI Ana.les. Calif. lot" 60214, $0272, 64582 
i-Iapaalum Chloride, Baker Analyzed It_,ent. J. T. Baker Chem-
i.cal Co •• Phll11paburth N.J. lot I 7117 
Pbene'ttwlblguani.de, hydrochloride. O.S. Vitamin Corp •• New York, 
N.Y. lotI 21 
Potas.ium. Chloride A..R., Malllnkrodt Chemical 'Wort",. New York, 
N.Y. lot # 6858 
Sodlum chloride A.R •• MalU.nlttodt Ch.lcal Works, New York. 
III '" Y • lot 11 7S81 
Sodium hydroxlde A..R •• Malllnkrodt: Chemieal Works, Nw York, 
N.Y. lot I 7708 
Sucros •• A.R. Malllnkrodt Cbemleat Works, New York.. N.Y. lot 
I 8360 
Tolbutamide j .odium .alt. The tJpjobn Company, Kalamazoo, Mich. 
lot ~ CJO 11,584-2 
Trichloroacetic: acid A.'ll",. t4alH.nlu:'oc.it ChGmical Works •. New York, 
N.Y. lot /I; 2918 
Tria (hydroxy"'nethyl aminGmethane) Primary Standard Grade. Slpa 
Chemic.., 1 Co.. St.. Louis II Mo.. lot t? 1125-812 
L.Leueine-C14 (U .L.) .... This was obtained from the New England 
Nuclear Corp. t B')ston, Mass. and was supplied as the hydro-
chloride dissolved in 0.0111' ;:tel. Since this exc ••• Acid aisht 
adveres91y affect the bufter system in the incubation. the 
i.otope was evaporated to dr-rness 1n the original vial under a 
stream of nl tro13an ga... Tht! dry am.ino acid (present as the 
hydrochloride) was than dissolved in sufficient doubly til.tilled 
water to Siva a final activity of 1 uc/SO ul of solution. The 
aqueous solution was stored in th.e freezer at .. So C and thawed 
immediately before USI!. 
The L_leueine_C14 (U.L.) was •• pacially .elected for iDoor-
PQrAtlon into protein studies because of ltB bith specific 
activity and relatively fe,~ metaboU.e pathways. Its lot # 1. 
212-31A-12 and its speeific activity is quoted ns 231 milll. 
curies/millimole. The radiochroraatogram. as determined by the 
manufacturer. indicates a purity 1n excess of 99.8~. 
auffer •• lue101u The bufter 801u1:1_ uaed .... that of 
campbell aDd Xenot (13) J.n thelr work Oft the 1Dco~oratlOD of 
radioactive amino acids into serum albumin. 4.240, of tr1a, 
1,864 g. of Ke1, 2.033 g of Ma01Z' and 51.35 g. of sucro.e 
were dissolved in doubly, .glass-d1st11led water and the rAsul-
tet solution was made up ta one liter. Concentrated HCI wa. 
a.dded until the pH was adjusted to 7.8 as m..sured by 4\ Beckman 
pH meter; this required approximately 1.85 ml. of the acid. 
The final molarity of the solution with respect to each component 
was: O.03.5Mtris; O.02SM KCt; O.OlM MgC12 ; and a.lSM sucro.e. 
Premix Solution: Two different premix solutions were used, 
depend ina upon the experiment. The composition of th ••• solu-
tion. is given in table Ill. Premix 1 wa_ used when there were 
no 18 !iIEo additions to be made to the incubation flasks; 0.30 
ml. of tMs .01ution vas added to each flask. Premix 11 was 
employed wben 80me other compound was to be added .&a ntE9 to 
each flask; 0.20 ml. of this solution was added to each flask, 
and the other addition was made in a total volume of 0.10 ml. 
so that the total incubation volume was tbe same in .::.11 eases. 
In experiment. wbere the basic premix differed from that des ... 
cJ:lbed here, it will be noted under the particular experiment. 
1 SO!::,\I I Of! OF HlSlU1S91IS 
Livers were obtained from ftllll8le rats weighing ISO .. 200 
grams which had been stunned by a blow Oft the head and a.cri-
ficed by decapitation. The livers were removed .s soon •• 
po.aible after death. usually within 30 .. 60 seconds. They 
TABLE: III 
COKPOSITION OF PRiHIX 
SUBSTANCE 
ATP 
'{{§MIX 1 
cre.tine phosphate 
creatine phosphokinase 
GTP 
SySSTAN9.E 
ATP 
PRRjlX 11 
cre.tine phosphate 
cre.tine phosphokina.e 
GTP 
CONC. 'miLs.o ml.) 
20,S 
172.5 
0,8 
cgnc. (.&/5,0 ml.) 
30,8 
2.58.9 
1.3 
6.9 
These conoentrations were experimentally determined to 
sive optimal incorporation of leucine.C14 into hepatic protein. 
(cf. Experimental Chapter. Part 1). 
were then rinsed in ice cold buffer solution, blotted dry. 
weighed. and ground sently with 2.5 volume. of tris buff.r in 
a Potter-Elvehjem type hOlllo,enizer at 700 r.p.m. for 5 complete 
vertieal strok... Th. homog.nization process was carried out 
o 
at 0 C. Unbroken eells, tissue debris, nuclei. and mitochon-
dria were removed by centrifugation at 12.500 &. for 15 minute. 
at 00 C. (Servell Centrifuge Model 8S-1, Serial No. 4796, 9.900 
r.p.m., r.c.f. 12,520 at tip). 
The supernatant .olution was car.fully decant.d into poly-
allom.r ultrac.ntrifuge tub.s. The.e wer. then centrifuged at 
10S,OOO & in an ultracentrifuge (aeckman Model L. 40,000 r.p~m •• 
r.c.f. 10S,OOO at tip) for 1 hour at 00 C. to sediment the 
micro.omes. The number 40 rotor was used for this proc •••• 
FollOwing ultracentrifu,ation, the micro.omal fraction 
appeared •• a pellet in the bottom of the tub •• while a lipid-
like layer was invariably pre.ent at the top. A portion of the 
cl.ar cell sap. s.en between th.se two lay.rs, was withdrawn by 
m.ans of a hypodermic syringe and stored in the cold. The 
remainder of the cell s.p, alon& with the lipid layer. was de-
canted and discarded. The microsomal pellet wa. rinsed with 1.0 
ml. of cold buffer solution and then re.uspended in buffer by 
,entle homogenization. This final .u.penslon was prepared in 
sueh a way that eaeh 0.40 ml. of solution would contain the 
microsome. derived from one gram of liver. Each incubation 
flask was .tarted by the .tmultaneous addition of 0.30 ml. of 
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cell sap and 0.40 ml. of microsomal au.pension. 
PROTglN ISOLATIQ!! 
After the flasks were incubated for the specified period 
of tim.. the reaction. ware terminated by the addition of 1.0 
ml. of l~ trichloroaeetic acid (TCA). Thi. prote1n precipitant 
haa the advant •• _ over perchlorlc acid (PCA) in that it pre· 
cipitate. more type. of pla_a protein. (99). The exact mechan-
iam of precipitation by either of the.e acids is unknown. 
Once the reactions were terminated, the contents of each 
tlalk were quantitatively tran.ferred to • gla.s stoppered 
centrifuge tube and centrifuged for 45 minute. 1n a clinical 
centrifuae to .eparate the precipitated protein from the super-
natant .olution. The protein was suspended in 5.0 ml of S'l~ 
TCA by .ean. of a vortex mixer and recentrlfuged. The preci-
pitate was then wa.hed three time. with 95% ethanol and three 
times with acetone in the .... manner. The effi.ciency of the 
14 
washes il1 removing non-incorporated leucine.C was determined 
by platina out a 1.0 ml. aliquot of each wash, evaporatins it 
to dryn •••• and cOUI'ltina the dried s .. p1e with a thin window 
Geiger-Mueller Counter. In another experiment. a 1.0 ml. 
aliquot of tbe final acetone wash from each of eleven flasks 
was treated similarly. The data in Table. XXIII and XXIV in 
the appendix olearly indioate that the above procedure provide. 
adequate purification. 
After the final acetone wash., excess acetone was removed 
by gentle suction w1th an aspirator and the preeipitate.dis. 
solved in 2.0 ml. of O.lN sodium hydroxide. A 1.0 mi. aliquot 
of this solution was taken to dryne.. in a planchet and 
counted in a thin window Geiser-Mueller Assembly oonlilting 
of a Tracermatic Se.B) Scaler. Tracerlab $G-iOa Mult1matic 
Sample Chan&er. and Tracerlab 5C-66 Printi.n& 'rimer. 
Mo correction wal made for the .elf-absorption due to the 
.odlU1l hydroxide since titi. wa. constant for eacn sample. The 
geometry of sample •• 0 plated wes exeellent; each planchet 
contained a unifom thin layer of solid material on the bottom. 
Ib29D GLU~QSi DiXI8HINATlg~J 
The detend.nation of blood glucose was performed by a 
modification of the Glucostat method (100). Tail blood was 
obtained from tbe animals under study, and the sertL-n separated 
from the eell. by centrifugation for 2 minute. 11'1 a 'Seckmaft 
Microfuse. The assay involved adding 20 u liters of sample 
(standard or .erum) to a small t •• t tube followed by 2.0 ml. 
of Glucoatat reaaen1:. The tube. were mixed by inversion and 
incubated at room temperature for 10 or IS minute.. The reaction 
was terminated by tbe addition of 1 drop of 2 Hel and the 
absorbance read at 410 m u in the Beekman micro colorimeter. 
Preliminary experiments indicated that the absorbance was not 
affected by tbe amount of HCI added, so this rather inexact 
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measurement of Hone drop" 1. valid. 
~tandard curves were plotted using this procedure for both 
a 10 and 15 minute incubation time. Thes. curves are shown in 
Fisure 11. It 1.s apparent from the grapns that the absorbance 
is directly proportional to tbe glucose concentration over the 
ranS. of 0 .. 600 mg:f. for the 10 minute incubation. Some devi-
ation is •• en at the higher concentrations in the case of the 
15 minute incubation time. 
The above procedure has the advantage of simplicity over 
other more common method., but it i8 not nearly as exact. The 
fact that a protein free filtrate was not prepared was taken 
into conslderati.on by running a zero t1me control with each 
sample. There ara otber li.mi.tationa of the mathod uled. but 
sinc. it was d4Iailfted to ,lve only an approximate serum sluco.e 
lavel (e.g. to determin. whether alloxanized rata had abnorm-
ally high blood lugar level) thes. were not felt to be important 
anough to justify the more tedious determination involving the 
preparation of the protein-fr .. !t.ltrate. 
YSE OF ALLO~~-D!AI&IIC AN'~~LS 
In several experiments it was desired to utilize the livers 
from rats made diabetic with alloxan. Prell.minary experiments 
ahowed that the animals were much more likely to become dt.abetlc 
if they were subjected to a 24 hour faat before the injeetion. 
Accordingly, the following procedure was utilized. 
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Twenty four hours before injection. rats wei8,hing 145 .. IS5 
grams were placed in separate metabolic cases and given free 
ace.s. to water but: no food. The urine was collected and tested 
for the presence of Slucos. (Clini.tix, Ame. Co •• Elkhart, 
Indiana). In all ea •••• the amount of gluco.e pres.nt was below 
the .en.itivity of the test. The animals were then injected 
with 20 ms/100a of alloxan monohydrate in 1.0 ml. of dl..tilled 
water and returned to their individual case.. They were now 
allowed fr.e access to both food and water. Urinary Sluco •• 
and k.tone excretion were checked dai ly (c 1ini.tix and Keto-
stlx, Ames Co., Elkhart, Indiana). All the ant.als treated 
were ,lucosuric and many ~.re mildly ketonuric.. The animal. 
were .acrificed 48 hours after the injection of alloxan and the 
teninal blood sugar value was determined. In,all ea.e. this 
was above SOO mg% and in two ca... was above 2000 1\&%. 
It was observed that following the injection of alloxan. 
the animals became hyperirritable and each was observed to 
lose a sipificant .. ountof wiaht in the three day period. 
The data from one such serie. of experiments are 3iven in the 
appendix in Table XXV. 
C!;!AlIIR I~ 
WERIM,§,NTAL.R§SULIS 
1. ESTABLISHMENT 0' A CELL.PREE SYSTEM POR. OPTIMAL 
INCORPORATION 01 LEUCINE_Cl4 INTO HEPATIC PROTEIN. 
Al?:houah the general requirements for the cell·free inoor-
poration of radioaotive amino aolds into protein have been known 
for soma time (11'). there i. still considerable variance in 
the literature a. to the proper conoentration of cofactors 
nece •• ary to ensure llUlXimua inoorporaticm. An illustration of 
this is axhibitad in Table IV in Whioh the cofactor concentra-
tlons used by several In .. stiaators are s"..rized. lecaus. of 
ehe obvious diff.rence •• lt was considered nece •• ary to determine 
s.. of the parameters of the protein-synthesiziDg system exper-
blentally in order to aahia ... optlmalincorporation. Much of 
the experlmental d •• ip at this staS_ was arrived at in an 
arbitrary fashion sinee there were no speclfio guidelines avail-
able. The tris buffer was chOsen because of its wide usea8e 
in somewhat similar experimeats, leuOlne-c14 was .elected a. 
the isotope bacau •• of it. hiab spaelfio activity aDd relae!:.,ely 
few .atabolic paehways; eraatine phosphate was employed .s the 
en.raY .oure. for re.sons of econ_d.cs; faale rats ware used 
because of their relative doc111.ty, etc. It is quite possible 
that another investigator might have • very different rationale 
and consequently would beain work with a considerably different 
system. 
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tABLE IV 
IRE CQ-iPOSITION OF INCYBATION MIXTURES USW BY XARIOUS 
INVESTIGATORS T2 SIUUX HIPATIC PR2Ill~ SYNTHESIS IN A 
C!LL-FRE& SISTEM 
INU~:rlGAIOR,S 
COl1PONENT HIZM!Q. (781 MYRtiiX (79 } KEJ.LlR (it 7l 
Sucros. 35 u moles/ml. ...---_. 175 u moles/m1. 
Tris SO u mole./ml. 40 u mOle./ml. ------
MgC12 lOu mole./ml. S u moles/ml. 2 u moles/ml. 
KCt 70 u mol •• /ml. 40 u moles/ml. varia.ble 
Thioethanolamine S u mole./ml. ...----- ---_ .... 
ATP 0.5 U lIole8/.1. 1.0 u moles/ml. 0.5 u mole/ml. 
PEP 5 u mOles/ml. 10 u moles/ml. 
Pyruvate kinase 25 u grams/ml. 30 u grams/ml. 
lOu mOleslml. 
30 u grams/ml. 
GTP 
KHC03 
L-A1aino Acids 
Isotope 
0.25 u mole./ml. 0.25 u mole/ml. 0.2S u mole/ml. 
...... -_...... • ... ---- 17.5 U 1101 •• /181. 
------ 0.05 u mOle/m1. ------
2.220,000 dpm. 100,000 cpm. 82.000 cpm. 
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ExatE&msnS l: lht R!l ••• s!. £140a fEem L!!!cine"'Q14 l!x ya.rl2Y1 
'rags leon , .9! Rak LieDI'· 
It has been previously shown that the oral hypoglycemic 
aaents affeet both the incorporation of leuC!lne .... C14 into protein 
and the eatabolism of leueine-C14 .a measured by 01402 evolu-
tion (22). It was desired to eliminate the .ffects on leucine 
cataboli~ so that th8 true effect on the incorporation of 
18uc:ioe-014 into protein could be studied. It was hypothe.ized 
that this might be accomplished by incubating only cell .ap and 
microsomes which would allow proteins to be synthesized, but 
which might not contain the enzyme. necessary for the catabolism 
of leucine. The followlng experiment was desi~ed to test the 
validity of this hypoth •• is. 
Three normal rats were sacrificed and a h~nog.nate prepared 
from the excised liver in the usual manner. The nuclei and eell 
debris were removed by centrifugation in the cold for 1.5 min-
ute. at: 700 x g. The supematant was divided into two part .. : 
one portion was kept' refrigerated for ineubation; the other was 
used to prepare microsom.. and cell sap as de.cribed in the 
preceding chapter. A s.rle. of flaaka was incubated at 370 o. 
for two hours. Each incubatiOft fl.sk contained the following 
component. in • total volum. of 1.05 al.; 2.0 u mol •• ATP; 10 
u mol •• creatiae phosphate; 0.4 u mol •• OTF; SO u 8ram. er.atine 
phosphokinase; and 1.0 u curie Leuclne.C14• The reaction was 
initiated by tbe addition of one of the following: whole 
homogenate; microsomal suspension only; cell lap only; or 
microsomal suspension plus cell sap. c1402 liberated ifl the 
course of the incubati.on was trapped in KOH in a center well 
and was later precipitated as BaC1403• The preeipitatewas 
treated as previously described (21) and counted in a thin 
window Gcd.soer-Mueller counter. Th.e amount of radioactivity 
present in the sar.tple was t~k.n to represent the degree of cat-
abolism of leucine that occurred. The results are presented 
in Table V. The.e data indicate that no appreciable amoW\t of 
leucine.al4 is catabolized by either the microsomal or the 
soluble fraceion of nomal rat liver. Thus by incubatin6 a 
microsomal system, the effects of the oral hypoglycemic agents 
on the inco1:'poration of lGUcine-C14 into hepatie protein may be 
stud1ed independently of their effects on leucl.l'le catabolism. 
Since it was not germane to the problem. the intracellular a1te 
of leucine catabolism WI not investigated further. but it 1;.,1OUld 
be reasonable to assume that it 18 found 1n the mitoehondrla. 
Since 1t was decided that it would be advantageous to 
study leucine-C14 incorporation into protein in a microsomal 
syatem ..... of the par.eters of such a .,.stem bad to be 
clarified.. The following seri •• of experiments waa d~.i&D.d to 
achieVe optlmal condi.tions for meaaur1ng prote1n synthesis. Not 
all of the experi.menta were run 1n the order given bere~ but 
rather .aconditions directed. They are pres.nted. therefore. 
1n a 10aiea1 rather than cbronological order on the followlns 
TAILE Y 
IILIbiI 9[ C142e flQ1 WCll!jt-C14 §X 
!MlOUS '1&£1:1911 or MQBMAL RAt LIID 
Fracel_ 
Count. per Mlnute of C14 
•• lac1402 
TRIAL I TRIAL 11 
I .... 
lh,'ho 1. hooogena'te 12,749 23.107 
Xicrosanes only 400 622 
Cell sap only 120 141 
l>11 eros Que 5 plus call sap 601 783 
.. .Nt I 
... • * 
Each value repre.ents the mean of 3 flasks. 
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pag.s. 
§IP.,&!mmt 1: Ib!. If',st .21 "O~'R. g9DC!9SEaS1S lW!1\ l!a 
InS9ERoratl!D s! L,uslne.C14 1D12 fltpat,s frps'Ln· 
o Incubations were run in trip11cat. at 31 C. for two hours. 
Each flask contained In a total volume of 1.20 m1.: 2 u mo1.s 
ATP, 10 u mol •• creatine phosphat.; 0.4 u mol., GTP; SO u grams 
creatine pho'phoklna,e; and the uaual quantity of microsomes 
and cell sap. The amount of L_leuclne_C14 was varled betwe.n 
0.5 and 2.0 u curies per flask. The ,eactlon was termiraated 
and the protein isolated and counted as prevlous1y described. 
The re.ults are ladleated sraphically in Fllure 111. 
l t is apparent fr_ this graph that the amOW'lt of incorpor-
ation is a lin .. r lunetie with respect to the isotope CODaen-
tration ow, the ranSe studied. It has been reported in the 
literature that upon the addition of 1ncr ... ina concentrations 
of a radioactive amlno acid to a cell-free system, a saturation 
1 .... 1 18 reached after which there ls no further increa.e ln 
incorporation regardless of the isotope concentration (119). 
Obviously, in the pre.ent experiment. this level bas not been 
attained and it would be econoalcally unfeaslble to run future 
ex,.ri.r:,~nt. at sucb a Mlh concentration of lsotope. For thls 
re&4cr,j :'H arbitrary cholce of 1.0 1.1 curie was .elected for: the 
isotope concentration; thl. deaislon r.pr .... ted a reasonable 
compromis. b.tween the conflicting factors of maxtmal lncorpor-
~ 
a.: 
u 
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fL CURIES 
'iaur. III 
I. 5 2.0 
ISOTOPE 
The Effect of Isotope Concentration Upon tbe 
Incorporation of Leucine .... C14 lnto Hepatic Prote1n 
ation and expen.e. 
It might be wall to mention the manner in which the incor-
poration data are expres •• d. All data were calculated first 
a. counts per minute. then .a counts/min./ag protein based on 
both the dry weight of the protein and on the biuret reaction 
of Gornall (33). As the experiments pro&r ••• 8<1. it became 
inerea.insly evident that the reproduce.bl11ty of the observa-
tlons was consistently greater if the actlvity were expressed 
8imply in terms of counts per m1nute (rather than .. s counts per 
minute per mg protein). Thi. ob.ervation was interpreted to 
mean that the error inherent 1ft m .. surin, the 1'rot8ift concen-
tration was Ir .. ter than the error involved in the various 
man1pulations of the expertment. For thi. reason, all data are 
expressed simply in terms of count. per minute. 
IDttIMnS! 1.B4!: 1M I'f_' .11 goac'si lbSsPlliSI ; .. ,,-
SEtSj.. YES l1lI InsUROfatlgn Sf. LtuSLlt:g14 !!l!.2 titDltj.S 
lrot'Y. 
Each incubation flask GOfttatned the followins oofactor. in 
a total volume of 1.0S ml.: 2 u moles ATP; 0.4 u mole aTr, SO 
u &rams creatine phosphok.ina.,; 1.0 u euri, l.euc1ne-C14; and 
the usual quantity of microsom,. and cell sap. The concentration 
of creatine phosphate was varied between 0 and 100 u mol... The 
result. of the., experi.ents are presented 11'1 'laure I V. 
The two .eparate experLments were run on different days and 
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Figure IV 
The Effect of Creatine Phosphate Concentration upon 
tbe Incorporation of Leucine-C14 into protein. (Two 
•• paE'ate ExpeJ:'iJaent. are depieted in the diagram.) 
each point was detemined in dup1le8t.. It 1s apparent from 
the sraphe that maximum incorporation occured at a creatine 
phosphate concentration of 30 u mol.s/ml. The inhibitory .ffect 
of higher concentrations has not beem previously reported, and 
may simply be due to sodium ion effects or increased ionic 
strength. Future experiments, then, were performed using this 
optimal coneentration of creatine phosphate as the storase form 
of ATP. 
ill?rW95 1: .IJlsl i(f,st .u. AIl. !t2DnptEISi.!D l!I!!1 sat. 
Ipqg[p2r!t~2D st k!YSlgt.c14 1n1! HIR'S'c Pt9Se~n. 
'rhe experuuantal proeedure was the... aa previously des-
cribed. Each flask contained the followioa cofactor. 1n a 
total volume of 1.05 ml.: 30 u mol •• creatine phosphate; 0.4 
u mol •• GTP; 50 u &r .. s creatine pbosphokina.e, and 1 .. 0 u curie 
of leucine-C14• The concentration of ATP was varied between 
o and 10 u mol •• /ml. The results are illustrated in Figure V. 
Max1mal incorporation of leucin •• C14 into protein is 
achieved at an ATP sone.ntration of 2 u moles/ml. with a very 
pronounced inhibition of incorporation at hi&ber concentrations. 
This inhibition by exce.s ATP ia the reason why an ATP gener-
ating syst_ (e.g. creatine phosphate-creatine phosphokinase) 
must be supplied to the media. It is unlikely tbat the mechan-
ism of the ATP-1ndueed inhibition ia solely concerned with 
campiexing Mg++. since the Mg++ concentration is 1 u mol.a/flask 
4000 
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Fi.gure V 
The Effect of A.T.P. Concentration upon the Incor-
poration ·of Leucine-C14 into Hepatic Protein. 
10 
while the inhibition by ATP ia evident at an ATl concentration 
a8 low .1 3 u moles/flask. 
Exnr!aent £: Ill! Effe£t .21 f\~f ConSel'l.tr..tttion ~qn !11.!. 
Ins2Eeorat&oD s! L!HSlne-C14 ~ H!2ilttS f£9te l n• 
The experimental procedure was the same a8 in the previOUS 
experiment.s. Three conoentrations of GTP were used: 0.0, 0.5. 
and 1.0 u moles/mI •• each point being determined in triplicate. 
Tbe results are presented in Table VI. 
Tbe data 8\''lf£,i;eat that the pres..nee of exogenous GfF has 
little or no ('!ffect on tho incorporation of leucine-c14 intr) 
prote1n. This conclusion is in direct conflict with numerous 
reports in the literature (41) (85). However. it is quite 
U .. kely that in the present case there was sufficient endosenous 
GDP and GTP ava1.lab le in the 11 ver homogenate to make the 
addition of further OfP superfluous. This view is strength.ened 
by the observations of Schmits 8t ale (92) that there 1s a 
conaiderable amount of GOP and OTP pre.ent in normal rat liver. 
Howe .... r. since there might be individual differenee. in the 
amount of endogenous suanine nucleotid •• in the livers ef 
different rat., it was decided to add 0.4 u male. af OTP to 
each incubation fla.k in the future to en lure that this would 
net be a llJlltlng factor. Secau •• 0.4 u mol •• of GT!" dld not 
inhibit the ineorporatinl proce •• , 1t was ftzlt that no harm 
could be done by thi. procedure. 
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'fABLE VI 
IHliflEQI OF ,rI', S;ONCPTMIlg! U,ON 'EWit 
, BC9lPOIATI2l! or t.._LEU!I&NI_SC14 IMI2 HEPATl~ flO'Eilfi 
OTP Coneefttratlon 
u mol •• /ml. 
0.0 
0.0 
0.0 
o.s 
0.5 
o.s 
1.0 
1.0 
1.0 
Count. per Minute 
2151 
2174 
2242 
2288 
2381 
2370 
1969 
2231 
1994 
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~!Re[1m!nt 1: The Effest !! eEl_tine Pb2lshok\naat 9gns,ntEa-
S12D. !m.2Q the Iml0 tpo£ation 2t. i..·nc lP._g14 .i!l1.2 h'2ati:sfE2:Fti a. 
The procedure was exactly the aame as m,ntioned previously, 
except that the concentration of the enzyme was now varied 
between 0 and 400 u grams/mi. The results as shown in Figure 
VI t.ndicat. that tb. presence of .xog.nous oreatin. phosphO-
k.inas. greatly stimulates the incorporation of leucine .. C14 into 
bepatic prot.in. The degree of st1aulation is ind'p8ndentof 
the amount of enzyme added over the concentration rang. studied. 
indicating th.:':rt as little as 20 u grams of enzyme i8 adequate 
for maximal incorporation. Future uperiM.nts were performed 
using 50 u grams of enzyme per incubation flask because of the 
difficulty lnvolved ln accurat.ly walehin! smaller amounts and 
beeaus. the cost of the enzyme was not a limiting factor. 
buNeDt!: .I.1l2 Etf!st 9.! t1t.Cb:0s9!l1 £~,r!!;ent"ati;qn Y2.5m. .ttl! 
14 ID94.lIRorat1o,D .2f. keusine-g .mt.2 Hsmat12 .f.Eot!in. 
For this experiment, the microsomes were prepared as usual 
and suspended in buffer so that the microsomes from one gram of 
liver would be eontalned in a volume of 0.4 ml. of suspension. 
Aliquot. of this suspension ware further diluted with bufter to 
contain the mierosomes from 0.5 gratfts of liver and 0.2S grams 
of liver. The reactions were initiated by the addition of 0.4 
ml. of the appropriate microsomal euspension and the incubation 
was run for two hours at 370 C. the cofactor coneentr.clOD was 
u 
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The Effect of Creatine Pbosphokina.. Concentration upon 
the Incorporation of Leucine-C14 into Hepatic Proteln. 
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the s.e as in the previous experiment. 
Figure VII indicates that the incorporation of isotope 
into protein is proportional to the concentration of microsomes 
added. This proportionality appears to be leveling off at the 
higher concentration of microsomes, but is not yet independent 
of the microsome concentration. Presumably, if the concentration 
were increased further, a saturation level would result in which 
the further addition of microsomes would result in no further 
increase in incorporation. It is, however, not feasible to work. 
at a higber concentration of mierosomes because of the larse 
number of anima ls which would be required f or each experiment. 
Thus all experiments were run using the mierosomes from one 
gram of rat liver. 
Exneriments .2. and lQ: Tbe Et,ess s! ll!!!. .2f. Incu);uaSiop U.ROft 
!h!. ID90reoEatlon !l! Legsye-c14 ~ H!eaSiS lEOS,lUe 
The incorporation of leucine into the protein of rat liver 
microsomes was studied as a function of the incubation time. 
The concentration of cofaetors was the same as that previously 
employed, and each incubation flask received the microsomes 
from one gram of normal rat U. ver. The results are shown in 
F igurel1Il. 
Trial 1 was started s:lmply by the addition of microsome. 
to the reaction flasks; all other components had been pre-
viously added. Since the isotope and the eell sap were present 
tosather for 30 - 45 minute. it was o.stble that formation 
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Figure VII 
The Effeet of !-acrosome Concentration upon the Incorporation of 
Leueine_C14 into Hepatic Protein. (The microsomes obtained fram 
0.25, 0.50, and 1.0 grams ot liver ware used for the experi.ental 
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Figure VIII 
The Effect of Time of Incubation upon the Incorporation 
of L~ueine_C14 into aepatie Protein. (Differenc.. in 
Exper1.m.ental procedure between Trial 1 and Trial 2 
are discussed in the text.) 
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of the sRNA-AA complex had already occurred before the incu-
bation was run. If this were a slow step in the protein 
biosynthetic process. then tbe time curve obtained would be 
artifactual. Accordingly. a separate experiment (designated 
as Trial 2) was performect. in wtli .. eh the incubation was started 
by the si.multafteous addition of both mierosomes and cell sap. 
t t is apparent from the graph that the time course of incor-
poration is qualitatively the same in both eases. This might 
be taken to indicate that the first two steps in protein 
biosynthesis (i.e. amino acid activation and transfer of the 
amino acid to sRNA) are not rate limiting in this system. 
The very rapid patterft of incorporation indicates that the 
reaction is certainly complete after thirty minutes incubation 
t1m.e. and that it is not necessary to incubate for two hours 
as has previously been done. Nevertheless. the longer incuba-
tion period does not result in any lowering of activity. indi-
cating that catabolism of the protein i8 not a factor. All 
of the succeeding experiments were run on the level portion of 
the curve. many for the full two hours simply because it was a 
convenient lensth of time. 
It should also be noted frem these experiments that the 
absolute levela of incorporation vary widely from day to day. 
This has invariably been found to be the case. and is probably 
the result of many factors. Such variable •• s the age. health, 
and heredity ot the animals would be expected to influence the 
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degree of amino acid incorpora.tion. Similarly. there exists 
il large number of experimental procedures which differ alightly 
from day to day and certainly have a bearing on this problem. 
The speed with which the liver is exeized from the animal cannot 
be adequately controlled; the amount of time it takes to waigh 
the livers w~y vary; the temperature of the buffer might be 
different. There are literally dozens of sueh. factors which 
may shange the absGlute amount of incorporation from day to day. 
Henee it is impossible to compare experiments run on different 
days, except in a qualitative sense. 
EJp!ryegt ll.= .I.b2 Effest .2! Ii.ms .2! fEe-Inglbat1.og Ueen 1ht. 
1nC2IPo,at1.on .2f. LeuSln$-sc14 .ir.n£2 HlB!tic fateln. 
The 'very short time required for maximal incorporation as 
seen in the previOUS experiments sould be due to a number of 
fastors. It might be that some substance needed for the re-
action is limiting; it mi&h.t be that the incubation temperature 
inactivates the enzymes or RNA; or it milht be a oombination of 
the.e effeets. This exper1Jnent was de.ianedto test whether 
the incubation temperature had an adverse effect on the ineor-
poratill! system. Mierosome. and eell sap were isolated from 
the li~·.rs of normal rat. and were pre-incubated togetber at 
37° c. to\.t varying periods of tl.me. aliquots were withdrawn and 
used to start the actual incubation by addition to flasks con-
taining the cofactors and isotope. The incubation was then 
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allowed to proceed for one hour before being terminated by the 
addition of 10% trichloracetic acid. 
The results in Figure IX indicate that there is, indeed, 
a heat labile factor present in the mixture which is adversely 
affected by the 370 C. temperature of the ineuhation bath. This 
heat inactivation l')henomenon accounts for a large part of the 
14 fact that incorporation of leuelne-C into protein i8 virtually 
complete after twenty minuteSt although it is not the only 
contributing factor since the microsome. and cell sap still 
reeal,n some activity after this period of tlme. However, it 
would be unprofitable to search for other factors, beeaus. the 
time of active incorporation would always be limited by this 
heat inactivation. 
EIRex:!ment ll: Ib! Effeqt .21 Sht 6dSi-tigB s1 UU1al!,11.Id 6mHl! 
ASlds .Y.n.2n ;the lDsoJ\Poratiog .2f. l,eyga.tU,_,14 iDa H.paSic fEot.J.n. 
Some investigators bave de .. ed it necessary to add a mix-
ture of unlabeled amino acids to the protein synthesizing ayatem, 
while others made no such addition, relying entirely on the 
andoa.nous supply (ct. Table IV). this experLment was designed 
to determine Whether such an addition was necessary or useful. 
Accordingly, a solution wes prepared conta1nin& 19 unlabeled 
L-amino acids (deta11~ are ~ivet"l tn the Appendix). Two simul-
taneous incubations ""Tilre run; one containing 0.043 u moles of 
each L-amino aCid, and the other eontalnln~ only the usual eom-
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Figure IX 
The Effect of Pre-Incubation Tt.e Upon the Incorpor-
ation of Leucine.Cl4 into Hepatic Protein. 
30 
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pounds. Flasks 1n eaeh group were incubated for varying periods 
of time and the reaetion terminated in the usual manner. 
Figure X shows a very slight enhaneement of incorporation 
in the ea.e of the flasks which eontained the added amino acid 
mixture. This was not considered significant enough to warrant 
eontinued use of the unlabeled amino acids except in the cas.s 
where .in %!.x2 experiments were performed. Th... wi 11 be 
d.scribed later in the chapter .s they arise. 
2 
. 
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. 
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Figure X 
The Effect of the Addition of an Amino Acid Supple. 
ment upon the Time Course of Incorporation of Leucine-
14 C into Hepatic Protein. (clo •• d circle.- no exo-
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II. EFFECTS OF THE l! VITRO ADDITION OF TUE ORAL 
HYPOGLYCEMIC AGENTS ON THE INCORPORATION OF LEUCl1:U:-
C14 INTO HEPATIC PROTEIN 
EI2e,1m'n~ ll: Eft'st!!1 the Con9,01:£atioo !!1 Three O,.l 
14 Hro9g1ycemie Agent. sm. 1b Inso£J?q[ation .21 L,uelne-C in~o 
HeRfS!s ProS,in .2t Nomal Rat •• 
Ten female rats were sacrificed and a microsomal suspension 
prepared from their livers in the u.ual manner. The microsomes 
and cell sap were incubated at 370 C for two hours with the 
optimal concentration of cofactor. as determined in the previous 
experiments_ No unlabeled amino acid mixture was added to the 
incubation flask. in this experiment. A known amount (0 - lOu 
moles) of one of three oral hypoglycemic .,ent. (tolbutamide, 
chlorpropamide, or phenethylbiguanide) was added to each flask. 
To ensure that any effects observed were not due simply to an 
increa.e in ionic .trength. control flasks containina similar 
amounts of sodium chlorid. were incubated simultaneously. The 
reactions were terminated and the protein isolated and counted 
a. previously de.cribed. The result. are depicted in Figure Xl. 
It is apparent from this diagram that all thr.e agents in-
hibit the incorporation of leucine.C14 into the liver micro-
lomes of nomal rats to approximately the same extent. Further. 
the degree of inhibition is directly proportional to the 
concentration of agent in all ca.e., amounting to approximately 
TOLBUTAMIDE CHLORPROPAMIDE 
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Figure XI 
The Etfeet of thft !n Vi~[2 Addition of Various Com-
pounds on the lneorporation of Leuc:ine_C14 into the 
Protein of Liver Mierosomes from Normal Rats. 
60% inhibition at a concentration of hypoglycemic a3ant of 10 
millimolar. The data obtained for sodiUll1 chloride demonstrate 
that this effect is not attributable to either an increased 
ionie strength or an increase in the concentration of sodium 
ions. 
The behavior of phenethylbiguanide in this system closely 
parallels that of the other two 4&8nt8. To verify the observa-
tion)the effect of pbenethylbiguanide concentration on the 
incorporation of leucine_C14 into protein was run a second time. 
The data from this confirmatory expertment appear in the appen-
dix as Figure XIII. The linearity of inhibition with respect 
to concentration of phenethylbiguanide is in contrast to its 
reported effect (22) in a whole homogenate system (mitochondria 
plus microsomes). This difference is attributed to the fact 
that leucine is not significantly catabolized in the microsomal 
system, whereas a great deal of catabolism (relative to the 
amount of incorporation into protein) occurs in the whole 
homogenate. Since it was shown (22) that phenethylbiguanide 
has a relatively large inhibitory effect on this catabolism. 
it now appears that the unusual behavior of phenethylbiguanide 
in inhibiting protein synthesis in the ~hole homogenate is 
really secondary to its effeet on leucine catabolism. Once the 
two effeets are separated, .s in the present experiment, 1t 
appears .s though phenethylbiguanlde acts in much the same 
manner as tolbutamide. 
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Experirl1ent .!l!=_ The E{tect .2! LOWtr Concentrati.ons 9l. the 
Qal !U!poglyeEiS Aau!fJtp !lS. .£h!! IncQrporation if Ltycine-C14 
inso H$Qa'E~S ProStia !11~omal Rats, 
Although the previous experiments demonstrated that certain 
concentrations (0 - 10 millimolar) of the oral hypoglycemic 
agents inhibit protein eynth •• is, this does not exclude the 
possibility that other lower concentrations might have exactly 
the opposite .ffect. For this rea.on it was de.ed .xpeelS.ent 
to ascertain the effects, if any, of the 1D. n;Eo addition of 
lower amounts of the oral hypo&lyeemic agents on hepatic protein 
synthesis. 
Duncan and Clark (26) report that the blood level of 
arylaulfonylurea required to elicit a hypoglycemic response 
~~ !ivo equals 10 - 15 mg~. Simple calculation demonstrates 
that this is equal to 0.31 - 0.51 millimolar, implying that the 
concentrations used in the previous experiment were consider-
ably above the "physiological" blood concentration. Similarly, 
they report that the blood level of phenethylbiguanide required 
for a hypoglycemic response is only 5 ug/ml. corresponding to 
0.021 u moles/ml. This would seem to imply that a totally 
unrealistic amount of PEB3 was used in the previous experiment, 
except that \';iok .It 411. (Ill) have reported that thia compound 
is grea.tly concentrated in the liver upon injection, so that we 
would expect a hepatic concentration of phenethylbiguanide to 
be considerably above the circulating blood concentration. 
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This incubation was performed in the same manner as the 
previous one. Four seta of flasks were incubated in triplicate 
containing respectively: no addition (control); 12.5 mg% 
tolbutamide; 12.5 ma'%. chlorpropamide; and 0.5 mg% phenethyl. 
biguanide. 
The results in Table VII indicate that these lower concen-
trations of hypoglycemic agents have no appreciable effect on 
the incorporation of leucine.C14 into hepatic protein of normal 
rata. It is posaible that a slight inhibition is seen in the 
eaae of chlorpropamide and phenethylbiguanide, but the aisni-
ficanee of this is doubtful. At any rate, it is certain that 
this lower concentration of the agents does not stimulate 
protein synthesia as might be desired for these anti-diabetic 
compounds. 
EI1?riment ll: Effect!l! l.bI eggsentration .21 Three Oral 
Hnol1rgtmj.C Agegt. sn lb! Incorpor.tl:gn 5!f. Leusine-C14 i.n£2 
aePltts PEosej.n s1 All0J!n-pj.ab,tJ,s RaS., 
Twelve female rats were made diabetic by the injection of 
alloxan as described in the preceding chapter. Two days after 
the injection, the animals were sacrificed and the microsomes 
isolated fram their livers in the usual way. The blood glucose 
levels of the animals at the time of death were all above 
500 mg.,. as described in the Appendix in Table XXV. 
An incubation was performed exactly as in Experiment 13 
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TABLE VII 
IHE EFFICT OF IH§ IN VITRO ADDITION Of A LOW CONgEN-
TRATION OF THREjE ORAl: HXPOOLXCPUC AQQ!TS ON IdE 
INCORPORATION OF LEUCINE-C14 INTO JijiPA'tIC rROTE\N 
OF NOR.M:t\L EtA TS • 
Incubation Conditions C.P.H. in Hepatie Protein 
Control 1704 
Control 1802 
Control 1855 
Tolbutamide 12.5 mg% 1742 
Tolbutamide 12.5 m8% 1742 
Tolbutamide 12.5 1081. 185.5 
Chlorpropamide 12.5 ms% 1543 
Chlorpropamide 12.5 ma~ 1534 
Chlorpl'opamide 12.5 109" 1672 
P.E.B.G, O.CS m@,% 1650 
P.E.B.G. 0.5 mg"" 1727 
P.E.B.G. 0.5 mg'%. 1653 
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where the concentration of hypoglycemic agent was varied between 
o and 10 millimolar. Again, controls were incubated simul-
taneously in which corresponding amounts of sodium chloride 
were added. 
Figure XII illustrate. the reaults of this experiment. It 
should first be noted that the absolute level of incorporation 
of leue1.ne-C14 into the H.ver microsomes of these diabetic 
animals is very much lower (by a factor of 10) than the level 
of incorporation found previously (Experiment 13) employing 
liver mierosomes from normal rats. When normal rat liver was 
EHDployed t the incorporation into protein was above 4000 cpm at 
zero concentration of agent; in the present ease it is only 
about 400 epm. This observation supports those of Robinson (91) 
and Korner (50) which were discussed in Chapter II. 
Further examination of th.se data is not especially fruit-
ful, in that it ia difficult to ascertain whether the in ViS EO 
addition of the agents bas an effect on protein synthesis in 
this case. It appears aa if tOlbutamide and chlorpropamide 
exert some inhibition And that phenethylbiguanide does not. 
The difficulty arise. from the fact that the incorporation of 
leucine into protein ia so depressed by the diabetic state 
itself. that it is extremely difficult to demonstrate further 
depression by the in yitEo addition of the oral hypoglycemic 
agents. For this reason, further experiments utilized the liver. 
of noma 1 anima ls. 
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Figure XII 
The Effect of the In Vit£o Addition of Various Compounds 
14 
on the Inenrporation of Leueine-C into the Protein 
of Liver Microsome. fram Alloxan-Diabetie Rats. 
t;xperiment ll.: ~ Effect .2! !.!!2 £m1 Hypo~,llcemle Asents ,gn 
the 1.ftso[J?o!,4tion ~f Leu,eine-:C:4 • 1,ysine .. c14 t !Z!.9. ~h!nxlalanin!­
cl~tnto Hepatic Pro~elq £1 Norm,l Rats s 
Although Experiment 13 demonstrated that tolbutamide, 
chlorpropamide. and phenethylbiguanide added in y1tro inhibited 
the incorporation of leueine-C14 into the liver microsomes of 
normal rats, it was not certain whether this was a a;.eneral effect 
on protein synthesis or one peculiar to leucine alone. Aecord-
ina1y, an experi.ment was deviaed to test the effect of the oral 
hypoglycemic asents on the incorporation of three different 
isotopes into the hepatie protein of normal rats. The hypo-
glycemic agents tlsed in this experiment, and in most subsequent 
experiments, were tolbutamide and phenethylblguanide. Chlor-
propamide was omitted beeause of its aim1larity to tolbutamide 
1n both structure and proposed mechanism of action. It was felt 
that tolbutamide and pherutthylbiguan1.de would adequately repre-
.ent the two major elasses of hypoglyc_ic compounds (i.e. the 
arylsulfanylureas and the guanidine derivatives), and that little 
would be gained by including chlorpropamide in the study. 
The th.cee isotope. used in this experiment were especially 
desitned for incorporation studies by Schwarz Bioreseareh Inc. 
(Orangebur!;,. New York, 10962). Each amino acid was supplied 
as the hydrochloride and each had the same specific activity 
(SO u curi.s/u mole). They were dissolved in doubly distilled 
water. and 1.25 u curi.s of the proper isotope was added to 
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each incubation flask • .along 'tJi tn the usual amount of premix. 
To some flasks in each isotope ~roup ~r0 ~dded tOlbutamide and 
phenethylblguanide to e final concentration of 10 millimolar. 
The incubation ,vas besun by the addition of microsomes and cell 
sap and terminated afteE' 2 bours in tbe usual manner. 
The results ••• n in Tabl. VIII 1ncU.cate that both. tolbu-
tamide and pnenethylbiguanide inhibit the incorporation of all 
three isotopes into protein. thus it appears that this effect 
is &eneral and not specific for a si.ngle amino acid. 
These data also vi.ndicate the original choice of leucine-
C14 as the isotope to be used. It ia seen fE'en the table that 
the control incorporation of leucine.CI4 into protein is more 
tMll twice that of lysine_C14 and some~ .. hAt bisher than 
pb.enylalanin •• C14• 
EIP![W.nta II .!95!!!: Ill! Eff!SS .2! l'ol!mtam&d, and fb,n'tbr1-
bimlan\de .!m the Inqo£20rl!&0ft s.t Lwclnt.c14 .1.DS.2 SolY1!le !.!1d. 
M\q;os9I!11y-bound PEote1g st NO'lll I!£ L~YlE. 
Whether the oral hypoglycemic aaants inbibited both the 
101uble and rnicrollomal-bound protein. or only one of th •••• 
was lnvestisatad. Previous experLments were concerned only 
with th •• ffect of th.se compounds On total TeA precipitatable 
prot.in i.e. both soluble and m1crolOll'1al-bound protein taken 
tog.ther. 
Accordingly. incubations were peE'formed .a usual in the 
TABtE VI!l 
THE,EP':ICT OF. ,THI 1.1 .!lTRO,,:<\.q-qITIO~ OF ~Q~BUTA!1lD.~ 
!,:ffiJ .Pliit!ETHXLBlGUANIOI Of! lID; INCORfORATI0lf OF 
tIgICIlttE_c14 I LY§iIN~"Ql.~. AN)2 .PJR:"ILALANlt'E ... C!4 INTO 
Ttm H~P~TIC '?'''9.!ttN 2r N.Q,!MAJ:o rt~1s", 
. • Ii!" , .. . _.11 ..... . .. - .. . 
I nC'llba t'1 on l .. eueine Lysi.ne Phenylalanine 
Condi-eions C.P .. M. C.P .. M. C.P.M • 
• 
Control 3420 1336 2648 
Control 3371 1252 2329 
TOlbutamide 1452 61.5 1741 
Tolbutamide 1367 604 1838 
PEBG 1918 852 1503 
PEBG 1900 669 1572 
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pre.ence and absence of two oral hypoglycemic agents. At the 
end of the two hour period, the reactions were stopped by the 
addition of 2.0 ml. of cold 1% L-I:eucine to each flask, followed 
by chilling of the flaska in an ic .... wat.r bath. This .erved 
both to slow dO'Wft the enzymic reaction and to dilute the 
isotope with a large .xeess of non-radioactive leuCine, so that 
any further incorporation would utilize the amino acid which 
was not labeled. 
The contents of each fl •• k were transferred to an ultr .... 
centrifuge tube (operation performed in the cold) by means of 
three .liquots (2.0 ml. each) of ice-cold buffer Solution. All 
tub •• ware centrifuged .t 40,000 rpm for one hour to sediment 
the microsomes. At the end of this time. the clear supernatant 
was decanted into centrifuse tubes and the pellet rinsed once 
witb 1.0 IIll of buffer. This rin.e wal added to the supernatant 
and the total was taken to represent the soluble protein. Sim-
ilarly, the microsomal pellets were transferred to centrifuge 
tube. by means of 6 aliquots (1 ml. eaCh) of cold buffer solu-
tion. Protein was precipitated in all tubes by the addition 
of trichloracetic acid to a fin.l concentration of 5%. The 
precipitates ware then washed and counted in the usual way. 
Table IX shows the results of such .1'1 experiment where the 
concentration of hypoa.lycamic .gent was 6 mK. From tbe mag. 
nitude. of the control inoorporations it is evident that 
rel.tively little soluble protein il relea.ed by the miorosome. 
in tne course of the incubation. This is somewhat surprising 
in view of the fact that the earlier time-course studies showed 
the incorporation of isotope into protein to be essentially 
complete within 10 - 15 minutes. However, the data do indicate 
that the addition of the oral hypoglycemic agents causes a de-
crease in the amount of leucine-C14 incorporated into this 
soluble protein. 
The data are not nearly as clear with respect to the effect 
of thes. agents on the microsomal-bound protein. It appears as 
though tolbutanlide causes some inhibition whereas phenethylbi-
guanide does not. In order to cL:,rify the picture, the aam. 
experiment was performed a second time with a higher (20 mM) 
concentration of a&ent. 
The results of this second experiment are unequivocal. 
Both tolbutamide and phenetbylbiguanide inhibit the incorporation 
of leucine-C14 into soluble and microsomal-bound protein. The 
inhibition seen in the soluble protein is of apprOXimately the 
same order of magnitude as that seen in the microsomal protein. 
These data eliminate the release step of the protein from the 
ribosome as a possible site of aetion for either of the.e agents. 
If the,. blocked the release of the finished protein there would 
be a large inhibition seen in the .oluble protein and little or 
none in the microsomal fraction. Since this was not the oase. 
we can conclude that neither agent acts by inhibiting the re-
lease of the completed protein from the ribosome. 
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TABLE IX 
Xlii E;ftr;CI 01 lHl IN VITRO ADDlI1S& Of 'EOLBUTAl'11DE 
AND PHENE'l,aXLllGIk\NlDE Od lUi Ifl90RPOMIIQN OF 
LEUC1NI-C14 1NAQ SOLUBLE AND HICiQS~L-19U£lDPB.QIilN, 
Incubation 
Conditions 
Control 
Control 
Control 
Tolbutamide 6 mM 
Tolbutamide 6 mM 
Tolbutamide 6 mM 
PEIG 6 DIM 
PEBG 6 mH 
rEBG 6 mM 
Soluble 
Protei.n 
C.P.M. 
236 
226 
223 
166 
178 
174 
175 
170 
169 
Microsomal 
Protein 
e.p.M. 
1637 
1616 
1580 
1297 
1351 
1269 
1592 
1484 
1575 
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ill?!fiLmsnt li l2. and AQ: The l!l !.i~f9 ~ !2! Actiog !If. ~he Iol-
but_ide IpMbi$igp. !d.. l!aRa;!' PE9t1in Sygtgelis. 
'rhese experiments. designed t (') loea liz8 th.e 81 teof inhibi-
tion by tolbutamide. utilized a some~~at different procedure 
from previous incubations. In each exper'l.ment. the eel1 sap was 
pre-incubated with the isotope and premix tor 10 minutes. Th. 
experimental variable. fell iato three groups; 
1)3 flasks contained only cell sap and isotope; after 10 
minutes pre-incubation the reaction (prot.in synthesis) 
was be&un by the addt. tim of microsomes. These served 
as controls. 
2) 3 flasks contained eell sap, isotope. and 6 u Moles 
tolbutamide durin& the pre-incubation; the reaction was 
initiated by the addition of microsomes. 
3) 3 flasks contained only eell sap and isotope during 
the pre-incubation; reaetion was initiated 'by the 
simultaneous addition of 6 u moles tolbutamide and 
microsome •• 
The rational of the procedure ts as fOllows: During the pre-
incubAtion procedure. the reaeti01'ls which occur in the eell sap 
alone can take place i.e. the first two steps leading to the 
formation of tne s - RNA ... l\A aomplex. If tolbutamide inhibits 
one of these steps. ies presence during the pre-incubation 
should result in an inhibition 'but if it ia added with the 
microsome., no inhibition 'Would occur beeause tbe first two 
TABLE X 
IHI RlEQI Or 1111 IN tlDO APRIIl91 Qr Jl~LBJlTN1'DI 
AND PH§NrtHnllQYA!lRI OJ! IHI ll!WRPOMilgn. 21 
Li!lg'NE.Ql~ lNIO S9LUBLI W tll£ROfSJJ6L-IQYND PJ.9'IIIN. 
Incubation 
Conditions 
Control 
Control 
Control 
follNe_ide 20 mM 
Tolbutamide 20 111M 
Tolbutamide 20 RIM 
PEIG 20 aM 
PEBO 20 RI 
PEIG 20 111M 
Soluble 
ProteiD 
C.P.l'l. 
.590 
566 
581 
136 
144 
134 
209 
161 
146 
Mlcros .. l 
Proteln 
C.P.~i • 
89.55 
8824 
8929 
1869 
2038 
1976 
1763 
1686 
1727 
-90. 
reactions have already taken place. The data from two such 
experiments are presented in Table Xl. 
It is apparent at first glance that the incorporation of 
leucine-C14 into protein is lower than that usually obtained 
even in the control flasks. This is in agreement with the re-
sults obtained in Experiment 11 which showed that pre-incubation 
lowered the incorporation of isotope into protein, probably by 
denaturin& some heat-labile factor. 
In order to clearly see the results of this experiment and 
the conclusions derived therefrom, it is necessary to summarize 
the data in Table XI and to briefly outline the steps involved 
in the classical scheme of protein biosynthesis. 
Summary of Oa till 
Experiment 19 
Oescription Av. C.P.M. 
Control 908 
Cell Sap + Tolbutamide 683 
Microsome. + Tolbutamide 622 
I. Amino Acid Acti vaticm 
II. T~an.ter ot Amlno Acid to .-INA 
experiment 20 
Av. C.P.M. 
1422 
904 
908 
Ill. Arrangement of Amino Acyl-RNA'. on Template 
IV. Formation of P.ptid. Bond. 
v. a.l .... of Soluble Protein 
TABLE Xl 
lUI 1" !lIIO SITE or AQ,tl2t! 9l iOLlUIAMlRl IIHII1IIQl! 
9f HlPAII~ fRatl1! SXNtHIIIS. 
Incubation 
Condition. 
Cont .... l: no Tolbut-
amide added 
A"ant p ..... t 
durin8 pre .. 
incubation 
As.nt added with 
.icro..... .fter 
pr •• 1.11CNbation 
C.P.M. C.P.K. 
89S 1453 
1004 1391 
82S 1422 
710 879 
694 901 
645 932 
610 915 
646 917 
611 892 
The first two of the •• steps occur in the cell sap. When the 
cell .ap alone is incubated with leueine-C14 (and premix) for 
10 minute., the fir.t two reactions would b. expected to occur, 
re.ulting in the formation of charged s-P~A. If the inhibition 
oceured at step. I or II, it would be expected that no inhibi-
tion by tolbutamide would be found if the ag.nt were added 
after the 10 minute pre-incubation. Actually, however, the data 
show that the incorporation was depr •••• d by the same amount 
whether the tolbutamide was added before or after the preincu-
bation. This leads to the conclusion that the inhibition by 
tolbutamide oceurs at the micro.omal level (Samewhere in Steps 
III - V). However previous experiment. (17 and 18) bave de-
mon.trated that .tep V i. not likely to b. the site of action 
of tolbutamide added in litro, leaving the events occuring about 
the template as the probable .ite of action. (This also in-
clude.; of course, the po •• ibility that tolbutamide affects the 
template itself, by interfering with the formation of m-RNA, by 
cau.ing disaggregation of the polyribo.omes .tc.) 
E!per!ment Ii: Ib! la Vi£Eo J!1! Rt AS£ion at lb! ChlorproQ!-
mid. Inhib1£ion ~ ijep!tic P£ot,&n Sygth •• t •• 
The procedure and reasonina involved in this experiment 
are preCisely the same as employed in the preceding one. The 
only differenc.s lie in the substitution of chlorpropamide for 
tolbutamide and the u •• of a larger quantity (2 u euriefl) of 
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isotope per in~lbation flask. The increasec isotope concentra-
tion w,s desitned to increase the incorporation at all levels 
so that the inhibitions observed 'l;V'ould be more pronounced. The 
results are presented in Table Xl!. 
The incorporation of leueine-C14 into protein was consider-
ably higher at 21.11 levels than before due to the increased 
concentration of 1.sotope used. But the results are qualitatively 
the Sil-me as with tolbutamide in that it makes no difference 
wh~ther the chlorpropa,mide is added before or after the pre-
incuba;tion period. In other 'IJOrds, the site of action of 
chlorpropamide is the same as that of tolbutamide. in so far as 
this experiment can determine. 8ecause of the structural 
Similarity of the two compounds, this 1s not a particularly 
surprising faet. 
i3Sperimtnt! .u g 12: Tbl l!1 YUriro !J.£! !l! A9~12n Sl1 the 
fhtn,tbYlbiaupnlde Igb1blSigg !l! H!R'~ls P£oS,ln S!Dth'l&s! 
14 For these experiments, 1.0 u curie of l.uein.-C was 
employed; the procedure was the same as previously described. 
Oatfl\ are ~iivel"l in Table XIII. 
AlthO'l.1,;)h the inh1.bition obs l::,ved in these experiments is 
not very sizeable (due in part, at leaet, to the low levels of 
inc:orporcStion achieved), the pattern is relatively clear. In 
all cases an i:'libition 1.s obs~rv.d in the flasks containing 
phenethylbisuanide, and it apparently does not matter whether 
tABLE XII 
ltiE IN XIIRO §lI' Of ActION Of: 1m; ¥tYtOIlROrAMID! IN-
HlllXlON Of ljIfAI1C PRQIEIf SYNtHE§I§ 
Incubation 
Conci iti OilS 
Control: ftO 
Chlorpropud.de 
added 
Ag_t pre.eat 
durin@, pre-
incubation 
A&en~ added 
with microsomes 
after pre-incubation 
C"P.M .. 
4043 
4280 
3846 
2683 
2.698 
272.7 
2415 
2534 
2451 
t ' •• 
'l'AB~E XIII 
Iae iN V~rRO Sl"ri Of ACTION Of THE pm.mtIll:a.B'QLJA~'D~ 
IN1J.I8r~lOI~ OF HQPt'\IIC ?ROIElN ~YNl'fiiSlS 
In 
lncubation 
Condltito1D8 
-
•• 
Control: no 
PheDethylblguanlde 
added 
Alent present 
durin& pr .... 
iDcubation 
"sent added 
wi tb microsG!.11es 
after pre-incubation 
£xperuutnt 
C.P.M. 
1429 
1252 
1298 
1101 
1094 
1024 
909 
1049 
22 Experiment 
C.P.M. 
1351 
1462 
1412 
1192 
1098 
1102 
981 
1078 
1069 
23 
the c_pound is added before or after: the pre-incubation. The 
concluaion 1. the .... al that reacbed for tolbutamide and 
chlorpropamide. 
The last fiva experiments demonstrate that the inhibition 
of incorporation of leucine-Ct4 into hepatic protain is very 
similar in site of action for three different nypo&lycesic 
asents; to lbutamide, chlorpropamide, atld phenetby lbiguanide. 
When added ia lit£9 •• 11 threa affect the biosyntbetic process 
somewhere at the microsomal level before the completed protein 
chain is released from the polyribosome. 1t is not .urpristns 
to find that the two arylsullonylure •• bava a stmilar mechanism, 
but it il unusual that the auanidine derivative (phenetbylbi. 
luanide) al.o follO'w. the s.a cours., in view of the many other 
differenc.s known between th.s. two cla •••• of compound. (21). 
The effeet of th... two ela.... of .gents on protein synthesis 
may be contrasted, for example, with their reported effects on 
ehO'l .•• terol biosynthesis (19) (73). Both the .ryl.ulfonylur~&s 
and the guanidine derivative. inhibit the !! litro biosynth~~is 
of cholesterol, but' their respective sit •• of action are mark-
edly different. On the other hand, both group' inhibit the !J1 
Yit£2 biosynthesis of protein ~nd their sites of Action are 
quite simi18r. How~var, it must be emphasized that th~ ~xp.ri. 
menta described do not prove tbet' the three compounds studied 
have the lame meebanillll $f action. but rather they indicate that 
all three aet at approximately the aame point (1.e. the 
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ribosomal le~l) in inhibitinl the incorporation of leucine.C14 
into hepatic protein !D litER-
111. ErnCTS Of THE IN VIVO ADMINISTRATION OF THE ORAL 
--
HYPOOLYCEMIC AGENTS ON THE 1! !IDQ IMCORPOlAT10N 
or LEUCINE-cl4 INTO HEPATIC PROTEIN 
hR!IJ.us~1 2ft .. 27: Iff.S;.If..t. Iwl! LIE,a &9 j'SSi • .9t 
Ie1Jwtgj,Qa .. !hi. 1D Vitro I Dt9G!EaJj.m .It LeuS1D,·c14 ~ 
HIHI&S letS,h, 
Tha experlm_ts up to this point have b.en concemed wtth 
the JB nlE9 addi'tiem of the oral hY'POg1yc_ic a,'Dts to a 
c.ll-fr.. syst_. ID ordar to d.t.rmln. wheth.r the lDh1biticm 
of prot.iD synthesis which was observed mlght b. of significanc. 
in more physiological circumstano.s. the followins s.rl.s of 
exp.rim.nts was d •• llfted. Usln, Whi't. feaal. ra'ts. tbe 'g.nts 
were injea'ted 1D Jtl!2. the 11 ver was .xclsact aft,r a period of 
tim. and the incorporation of 1 .. O'1ne.014 into liver protein JJ1 
n;,o was m •• sured. Such .xperlJaent8 are far .or. c_plex in 
r.gari to 1nterpretation becau •• a numb.r of conflietina faotors 
misht contribute to the final r.sult. ror.xampl •• the inj.ction 
of tolbutamide into aft ant.mal .t,ht b. expeeted to produce at 
l .. st two antaaoni.tic r.sults: the tolbutamide it •• lf would 
inhibit the biosynthesis of prot.in .a discussed previously. and 
the tolbutamide would act Oft the paner .. s of the ana.1 to stim-
ulat. the prOduction of insulin which ift turn would acc.l.rate 
the biosynthesis of protein. The D.t ,ff.ct obs.rved would de-
pend on wbich of the ••• ffects was of the larg.r .. ,nitud •• 
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Four f.al. rats weiahing approximately 1 SO g. were employed 
in each expert.mer":. T1:iIO were injected intl'aperltoneally with 
0.3S millimole. of tolbutamide dissolved in 0.5 m1. of distilled 
water. and two were injected with an equal quantity of sodium 
chloride. The an~als were sacrificed after 2~ hours without 
food and a separate hamosenate made from the liver of each 
antmal. The microsomes and cell sap were isolated and the protein 
content of each suspension was measured and found to be very 
neax.-ly equal. Eight incubation flask. were run, utilizing tbe 
microsOlR&l au.pen.1Ofts fram the four animals. Terminal blood 
sugars indicated that the serum glucos. levels of the tolbuta-
mide-treated animals were an average of 44 m&~ lower than thos. 
of the control anunals. Tabla XIV illustrates the x.-•• ult. fram 
the first two such experiment •• 
The da t& obtained 1n the.. experiments were not consistent 
because of the wide variation in incorporation between different 
animal. as reflected in the ditferenc.. in incorporation in the 
oontrol &nLmals. While the relative incorporation of one •• lln .. 
injected anbnal waa approximately 2300 c.p.m •• that of the other 
was about 4100 c.p.m. Such variation of controls pre.lude. the 
possibility of drawing any definitive conclusion., althouth the 
data might indiaate that an inhibition of protein synthesi. is 
observed in the livers obtained trom the tolbutamide-injected 
animals. 
It was felt that the wide variation in the ability of the 
Rat 
TABLE XIV 
I'FECT-9F INJECTION OF TOLBYIAMIDE ON THE IN VIllO 
INeORPO~~I.ION OF LEUPINE .. g14 INTO IilfATIC PRotEIN Of 
NORMAL RATS (NQI IrlII§E MI§;l. 
Experiment 24 Experiment 25 
Number 
Injection 
Given c.P .f1. C.P.M. 
1 saline 0.35 lit Kol •• 23S5 1583 
1 .. 2362 1562 
2 n 4110 2681 
2 .. 4170 3049 
3 tolbutamide 0.35 m Mol •• 1012 1592 
3 " 1017 1563 
4 H 2195 1421 
4 .. 2304 1494 
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14 in(U.v1dual ant.m.als to incorporate leucine-C into. hepatic pro-
t.ln .lant be due to. differances in the genetic makeup .f tbe 
aalmal.. In order to. control this varlable, litter-mate. were 
_ployed and the ... _parisi_C. were repeated twice. The 
re.ult. are presented 1ft Table XV. 
The.. re.ults are IIlUch more c8l'lslstent than th •• e obtained 
f~ experiment. in Which I1tter-mste. were not used. The com-
bined evt.dance of thes. four exper1raente SUU.sts 8troaaly that 
a 81nsle acute do.e of t.lbut_id. (0." m m.l •• ) deer ..... the 
oapacity .f the aniaal's liver to incorporate leucine-C14 1ato 
hepatic proteiD 1a a eell.fr.. .y.t_. Th1a impli.. t:bAt tbe 
dlrect lnhibitlon of thl. amount .f t.lbutamld. is sreater tban 
the 8tbNlatlon caused by the In.r.... ln ln8ulin secretion 
brou&ht about by the c_pound. The.e r.sults 81ant be compared 
witb those o.f Recut and 'lscber who. reported (88) thAt tbe acute 
lnjectlon of 20 ms tolbutamide/lOOs rat had no. slgnificant eftect 
on tM lncorporatlon Gf slYCUUI_C14 into. rat-llver .11ce. ,Wl 
viCEo. The dlft.raM between their re.ults and those rep.rted 
here may lle t.n the tact that a larser inj.ction .S8.1 veil in 
the •• exper1ments (.3' m mol •• per rat .. 70 mg/100 g). It i. 
ala. po •• lble that the .ffect 18 not •• en 10 llve~ .lia ••• but 
only 1ft a cell-tree system. Thi. latter explanation. howewr. 
..... by tar the 1... likely of the two. 
1 
1 
2 
2 
, 
3 
4 
4 
TABLE XV 
mlC;: 51l ,"JlCTIO! 91 t OLIutN11QI ON Tm; II ntBR 
P!~TI9l! Ql !rAlSC'I.-C 1 4 am iJRttllC r.BfBlll 
9ll!OJt1Ata IAtI (wna HAm Y'lRl. 
'a1iDe O.'S • Mole. 2504 
.. 2381 
.. 3191 
.. 3131 
Tolbut .. ld. 0.3S • Mol •• 1724 
II 1837 
.. 2141 
.. 2216 
2223 
2195 
2640 
2820 
863 
882 
966 
930 
.103. 
ilR';:iml!'!~!§.: SCIHt!d..!. Sialll tar,! &D,.Rti& st 
!tlllgrttrqpgldl s lJlI la Iitrg lacgEP9raSlaD .if. Leus1.pe"y14 
~ HteS's fro'!!!, 
Tbe experimental procedure was the same in all reapects a. 
that used in the previous experiments. Each rat we. injected 
with either 0 .. 35 n'l Moles of chlorpropamide or 0.35 In Moles of 
saline and the livers vera excised and hCll1logenlsed 2y hour. 
after the injectiens.. Litter mat •• were employed in the 
experiment .. 
The results in Table XVI indicate that the la ~ injection 
of chlorpropamide in a single acute injection of 0.35 m Moles 
acts to inhibit the 1n ]iSER incorporation of leucine ... C14 into 
hepatic protein. This effect 1s muoh the same as that seen 
following the injection of an equal dose of tolbutamide .. 
Ilmtllaa!!2.: iffu.l 91 !. Slasl! YEll ,n iuti. .It btDtSbyl ... 
JlillMN.41 .E .£be 18. YUn lDsU'urat, • .If. LtvsLn .... y14 J.IWl 
D'MS&S frStb. 
The procedure va. the s._ .a used in the precedlna exper-
la_t. except that each an"'al received a do.e of pheD.thyl-
blsuanlde of 0.1 II lIole rathfno than 0.35 II 1101... The larger 
amount of tM. agent was dl.scovered to cau.e the death of the 
animal. before they could b, uled 1ft the exped.ment 1.1: •• 11. The 
eau.e of death was probably a fatal hyposlyeaaia. 
The result. in Table XVII indicate that this cOlBpound i8 
Rat 
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TABLE XVI 
I"ICT or lR,zIQIlQl $lit cHltOlPl9PN11QE 2ft lHi. IN !ll]O 
I "Q9BPORAl 1 Oft or LIUCINE-C1• INtO HlrAIIC PRQIIIN OF 
I9IMt:L MtS (LlnCS-MTES Y§ml. 
C.P.M. 
Number 
Injection 
alva 
1 saline 0.35 m Mol •• 1527 
1 .. 1710 
2 .. 2256 
2 .. 2049 
3 cb,lorprop_ide 0.35 m Mol •• 1443 
3 .J 1300 
4 .. 1110 
4 .. 1071 
.1 OS • 
• imilar: to the other two studied in that it. admln1.tratlOll 
ia l1!I can re.ult 1n a decrea •• ln the abll1ty of the ant.a1a 
11 vel' to 11'lcorporate leuclne-C14 lnto pptein iI. ntn. 
The.e experllRents lndicate that • lar,8 lnjectiOll of uy 
of these as_ta can re.ult in a d.er .... of protein anaboll,_. 
Thi. implie. that the direct effect of the c.pound Oft prot.in 
.ynthe.i. is of a are.ter .asaitud. tban otber: effects .ueh •• 
tba stlaulatlon of lnsu11n productlon by the paller.... It.eeraed 
qult. likely that ... 11er 1ajectloas of the a.eats would r.ver •• 
the .ff.cts .1lCI a nat pr~.in 8IIaboll_ would ba noced. aaeaftt 
and 'l.cher (88) hpol:'tad .. 1.fter .... ln the lDeorporatloa of 
leucine-C14 lnto protelD of rat liver .llc. it the donor ant.als 
weI'. adad.DlsteC'ed to1but_lde (20 IlIIIOOa> for 4 • S day.. nn. 
ber .... lD lDcorporatlOD by the tolbut_lde treated anwal. 
was oODald.C'ad to b. a reault of an laor .... in unll. ..ore-
tlOD fr. the pea...... The next _perla_C. were de.lped to 
verify thi. ob.el!'Y8tlOll anel extead 1t Co the othaC' oral hypo-
.1yoaa1o a.ent, pbenethylblSU8Dlde. 
1a'Rt1'MD11 JP - Jl: IC' .. .21 IUMIE la 1tatl nl .t1 101\115'-
IWIa ... J.bIla XiSlo lannoYSl.1I .If. lr.nsl at:c14 .\W fttp!SJ.' 
lat.J.p, 
, ... le 11tter ... te. were injected with 0.1 ••• 1. of tol-
butamlele .ubcutaeou..ly for a period of tl.me. Control udma1a 
were inj.cted wlth .. equal quantlty of •• 11n.. Thi. _ount 
Rat 
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TABL! XVII 
KFECt or Ul,mCTION Of PHguHILI1GUAN1Pi ON Imt II 
VITIO lNCORPO~110N or l.tPlCINI-914 IN10 HEP"TIg PROT,,]! 
or !9JY1AL M1.§ (LIUEI-H!\TIS usmu. 
C.P.M. 
Number 
lajeetion 
given 
1 aaline 0.1 m Mole. 2540 
1 .. 2504 
2 It 2991 
2 It 3096 
3 PEBG 0.1 m Mol.s 1790 
3 .. 1745 
4 .. 1828 
4 .. 1865 
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(0.1 m mole) i8 equal to approx1mately 30 m&.~!nieh corresponds 
to 30 maJrat or 20 _&/100& since the weights of the animals 
were very close to 150,. Two 8xperiments were run, each using 
3 control ani:llala and 3 tolbuta'l'ii-1e treated ones. In '3:xper1ment 
30. the animals ~~re injeeteddaily for e. consecutive days and 
sacrifieed on the mornios of the ninth day. In Exper~.nt 31, 
the animals were injected daily for 4 consecutive days and 
sacrificed the following mornina. A separate homogenate was 
prepared from the liver of each animal and the usual incub~tion 
performed. 
Tb.e results in Table ::.'1111 indicate that no net effect is 
found in this type of experiment. the data demonstrate neither 
an inhibition nor a stimulation of protein biosynthesis. This 
is in contrast to the preViously mentioned work. of Recant and 
Fischer (88) who reported a stimulation of protein synthesis 
(us1nS incorporation of 51yc1ne.014 into liver slice protein as 
• criterion) under the same conditions. In the present experi-
menta, it appears as though any stimulation of incorporation due 
to an increase in in.ulin production ie Yery nearly balanced by 
the inhibition of incorporation due to the tolbutamide its.lf. 
The pre.ent dataare reasonably consistent and do not lend com-
fort to the theory tbat tolbutamide exert. an anabolic effect 
¥be administered 1! .D.D due to an increased inSUlin production. 
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TABLE XVIII 
KFI£&: OF Yf~tle lR:li£I'2!~ or IOL8U:wJ1Di Qf! lUI 
'" Vli!9 1!C9RfOMT101! OF LlY)!lNlwC14 INtO liEtAll)! 
fi.2II'l! 
Rat Injection Experiment: 30 Exper1ment: 31 
Number Givea C.P.M. e.p.M. 
1 Saline 0.1 m Mole. 2022 7026 
1 .. 1983 7264 
2 .. 2586 122.45 
2 .. 2604 12397 
3 ft 2904 114.50 
3 » 2844 11723 
4 Tolbutamide 0.1 m Mole. 2026 11450 
4 .. 1917 11407 
5 tf 3061 10380 
S .- 2970 10135 
6 .- 2376 10067 
6 .- 2501 9934 
Experiment 30: Rat. injected daily for 8 days 
Experiment 31: Rat. injected daily for 4 days 
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b2!r1.m!m~!! ~2 .. 33: Eff.S'.at Repealed IDj"~'on! s1 E!bM.'b!l-
14 bisuaaidl Rn 1b! In Vit[O Inco'poEatiOD ~ Leucine ... C !D1! 
Bill"$! Piq;IiD. 
The procedure followed was identical to that uald in the 
pr.oeding experimtnts exc.pt that • amall., doa. of this oral 
hypoglycemic agent was used beoaus. of lts great.r toxicity. 
The animala were injected daily for a period of 8 and 4 days 
resp.ctively withelther 0.02 • mole. pbeftethylbiguanide or 0.02 
III mol •• sodium chloride. Incubations were performed as usual 
the day aft.r the final injection was Liven. 
Th. data in Tabl. XIX dlmonstrat. that th.re i. no con.i .... 
t.nt .ff.et upon the ia Xilil incorporation of leuctn._C14 into 
h.patio protein by daily injection. of this amount of phenethyl ... 
biauanid.. This is similar to the ca •••• en When tolbutamide .s 
injected daily for a period of tta.. The.e results are signifi-
cant in tbat they show that neither o.f these a,ents caus. a net 
stlmulatlOl'l of !\epat!.c protein synthesis under the condit.ions 
studied. This is in contrast to results seen followina the in-
jection of insulin (91). and may be indicative of a failure of 
tho oral hypoalyc_ic asents to adequately control the prote1n 
inbalanoe a.sociated with the diabetic state. From this work, 
it appears as though these compounds are inferior to insulin in 
this re&ard becaus8 they fail to reproduce its stimulation of 
protein synthesis. 
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TABLE XIX 
E:FFiCT OF REPEATED INJECTI9H§ qr PHENEIHYL~tGUAIU.Di 
QN THE 1ft VITRO INgORf2Mil0N Of blWSiUn;:.g14 INTO 
fmPATIC PROTlt! 
P bill. 
Rat Injection Experiment 32 
Number Given C.P.M. 
1 Saline 0.02 • Moles 96S 
1 It 916 
2 It 1328 
2 Q 1443 
3 n 1730 
3 It 1700 
4 PEIG 0.02 • Mole. 1595 
4 .. 1540 
5 It 
--
.5 t1 2310 
6 .. 2030 
6 II 1880 
Experiment 32: Rata injected daily tor 8 days 
Expert-ant 33: Rata injected daily for 4 day. 
Experiment 33 
C.P.M. 
6110 
5964 
9836 
9837 
8003 
8438 
7426 
7126 
6224 
6224 
8671 
8746 
lDIl1mentl 34 - ~l l(f'S5 1l1ln l1x2 101'9;108 sf. IolkYtgj.d. 
Jill !b~R!lat\ve i\~i.l"tx sl t1.\.eroIQll\etl !!ll1 C!211 Sap !! .lnegrpor.S! 
LtyIln~C14 ~to HIR!tic Protein. 
Two aeta of l!tt.r~c.at cona18tin& of three aD~a18 eacb. 
wen .eel in .. ch expes:iaent. Oae a.t of animal. wea injected 
with 0.35 • molea of sallft. aad the other with aft equal quaatity 
of tolbut_ld.. Atter 2\ hour •• the livers from each set of 
aalmal. were pooled and two •• para •• hem",..at.a (trom aaU.!le-
..... ted aad tollNt_ide-treated .. ata) wer. pr.pared. The micro-
.... 8ftd "11 .ap fre .ach ~ .. _at"! ,,,eN 1.olated aad kept 
•• pa ... t.. Four •• ta of experlmental oODcU.tions we!:. employed la 
thls expec1.aae1ltt one s.t of lneubatlon f task. contaln.d both 
.1eroa ••• and cell-.ap , ... contl'ol an!.mal., a .eoOftd s.t COIl-
tat.ned the .. 11 up fl'. cOIItrol aa1lDala and the aicroscm. •• frOll 
tolbut_lde-injecrted on.a; a ChiX'd uNd cell sap frOID 'tolbuta-
aide-injected arti ... al. but microsCIme. frem cOD'trol OD.S; and the 
fourth •• t .. plO,Yed both micro._ •• and c.ll sap from tolbuta-
aid.-treated animala. In thla lIaN1... it wa hoped to learn .om .. 
'thina about Cbe J.a :AD 8ite of actl. of tolbut_l •• 1n respect 
to lta 1ab1blclon of hepatie protein biosynth.sis. The re8ults 
.f the.. _pttrimenta are auanarieed in Tab 1. XX. 
The data 'emon.trat. an inhibition of incorporation of 
leucine-C14 tnto hepatlc prote1n When the cell-•• p uaed le froa 
the an1mal. injected with tolbut_icte. but no lab1bU:iOll when. 
only the .1 .. 8 •• a t .... &rd.mala injected with tolbutamide an 
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TABLE XX 
EIFIOT. Or IN n VO Ift,J:ttQrloR OF I2LIlJIAMIDE 2ft tHE 
IlLATIVE ABILITY 0' MlcaoSQKis AND gILL SAl TO lU-
QQ!f9RAtl Llu9lRI_c14 lKIO §lPAIlg Plotili. 
CELL SAP 
SOURCE 
Control Animals 
Tolbutamide Animal. 
Control Animals 
Tolbutamide Animals 
KICItOSOMES 
SOURCE 
COURTS PER MINUTE 
EXP.34 EX'. 35 EXP. 36 
Control Animals 3047 2447 1870 
Control Animals 2383 2049 1457 
Tolbutamide Antaals 3185 2556 1797 
Tolbutamide Animals 2559 2159 1425 
Each datum represents the mean of three determinations 
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.ployed. Further, the inhibition by the cell-.ap alone from 
tolbutamide-injected animals is of the s .. e mapitude .s that 
obtained when both cell sap and microsomes are obtained from 
tolbutamide-treated animals. It appears not to matter which 
.et of animals the microsomes are deri.ved from, but an inhibi-
tion of protein synth.sis i.s always seen to occur if th.e cell 
sap is derived fr_ the tolbutamide-treated animals, and no in-
hibi.tion i.s ever •• en when the cell sap com •• trem the control 
animals. 
At first alec.f these reaults.iaht appear to contradict 
those found .1n DIEo where it was concluded that tolbutamide acta 
at the microsamal level. There is really no contradiction, b.-
cause the tolbutamide i8 not shown to be actina in the cell sap 
bere, 1t i8 merely pr ••• t in the cell .ap. Evidently. when the 
an:lmal 1. injected with tolbutamide, it realains dissolved in 
the soluble portion ot the cell and doe. not bind to any extent 
with. the microsome.. Thus when one adds the cell.sap trOll an. 
animal previously injected with tolbutamide, he i8 in .ffeet 
addiftl a dilute solution of the compound. ThiS, then, cause. an 
inhibition of proteln synthesis s_ewhere at the mlos:oscma.l level 
but the tolbutamide ltaelf does not bind to the m1croao.e. to 
any extent. On the other band, when Ofte adds microa.es frem. 
tolbut.lde treated animala. he 1a 80t addln& anyapprec1able 
amount of the compound and, 1f normal cell-a.p i •• ployed, the 
i.ncorporation of leucine-C14 into protein is not depre •• ed. 
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The •• experimertt. indioac. not only Chat tolbutamid. doe. not 
bind to the Illerosom •• when lnj~ed a aD. but al.o that it 
does not oaus. any irrever.ib 1. change t.n the micro.... slBe. 
they still retain their no~l capacity to incorporate leuctn .. 
Ct4 tnto hepatic prot.ln. 
IXMrJaaS. ~Z - ~'I 1""'.1[ 1a liD '8"1. • .It ttMttiD'A-
ItlrPMllr' .... I'LtI&YI ."&.11% .II. Ml ...... 11.4 C,ll I!.a 12 
'_OKlt, Wt1at::Si14 1111 iM'IItS bllfj,p· 
'nel •• l,. the .... ftC of .. cr •• ·.-owZ'· experi.aellt. w.re 
perfoc.ed u.lDa pbeDetb,rlbl..-nlde lal.ea. of tolbu ... ide •• 
the 01'.1 hypoSI,....i. aseat. T'M result. prel.tecl la table XXI 
are WS'7' similar to tho •• fOWld pnvloualy for tolbutaalcle. If 
the cell sap t. olttaiDed frCllD an animal pnvlOU81)r 1njeocecl with 
plumeth"lblpumid. t tun will be • d.cr •••• in ebe Ja DID 
14 lncorporatiOl'l of leuolDe-C lftto hepatic protein. Then is DO 
eff.e. on the 1Deos-poratiOD of leuot.ae-C14 lnto pC'Ot.ln wbeD only 
the .10ro._e. are d.r1.ad Ire. a pbeD.C~lbiJU&ftid .. laje.ted 
anlaal. The •• reeults an lntes.-preted •• beforel the pben.etbyl-
blp&Dlde. Itke the toll.Ntamlde. is present ln the cell .ap la 
l.lutlO1l and i. n.. .ppnoiably bound to the .10ros_.s. Tbe 
slal1ar behavlor of the two a_poundl 1. not U1lUIU&l 1ft tbls 
tns .. aa •• ala_ both are water s.lulll. and .1allt b. expeC1:ed to 
&CCNlRulate ill tbe solubl. ponlGl'l of the oell. 
-11S .. 
TABLE XXl 
IfFiCt or 1ft V,yo INJikil21 Of PHiNiTHXLjliYhN1RE QI 
Alii i&!i\tlU All'=:ItX Ql MlCi2t9JiS Ala Qilwlc sal to 
INy01PQM11 LI~ID_C14 IU9 HlfAtic pmill • 
• 
CELL SAP MICJ.OSOMES cO'JRTS PEa Mll!ruT! 
SOURCE SOURCE EXPEltDtENT 37 IXPDlMENT 38 
I I I , , 
C_te ... 1 6nlmaia Ccmterel Aral ... la 2528 2416 
PDQ Anlmal. Cont:l'Ol A.1Ml. 1810 1489 
Cemcni Aai.Dlala PDO Aa1mal. 2S63 2218 
PIIG Anlaala rEBa Aa1m&l. 1790 1372 
U I 
IV. ~::;UMMARY AND COliCLUSlONS 
A lthouifth a lar,. amount of work has been reported in the 
literature on the effeets of insulin on protein biosynthesis, 
very little attention has been paid to the Qorr$spoudlng effects 
of the oral hypoSlycfim11c a,gents. Since th.ese COl'4pounda are 
widely used '.n thtil control of eertnin types of diabetes, it was 
considered worthwtd.le to investigate their effect Oft protein 
synthesis for two r86eOftS: first, to ovaluate th.eir effLcacy 1n 
the control of the ent1re diabetic statf:', and second. co obtain 
some inSight. if potulihie, into their mechani.sll'l of action. Two 
particular compOtmds ",ere studied in deta.il; tolbutamide, a8 a 
representatlve of the arylsulfonylure. compounds. and 'l,)henethyl-
bis,U4nide, as a representatiw of the guanidine derivatives_ 
Thes. two classes of compounds haft been shown to differ in &any 
respeets. a ftnding which il usually in~erpreted .s indicating 
different mechanism. of 4cUiOft. 'the arylsulfonylureas reduce the 
fa..tins blood sUiar level of bt.ct and partially pancreatect-
omized or mildly alloxan diabetie anima.ls, but they do not do 10 
after: total pancreatectomy in d08S. rabbits. rat., or man, nor 
in animals made severely diabetic with alloxan (77) (110). These 
observations have been interpreted as indiaating that tolbutamide 
acts by sti.aulatln& the paner_. toproduee more lnsuU.n. The 
mode of action of pbenethylbiauanl.de differs markedly from that 
of the arylsulfonylureas a8 evidenCed by the feeta that tMs 
compound 1.8 aft effective ltypoSlyc_ic ageat in pancreateotcalzed 
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an.imals (82), in severe alloxan diabetes (102). aDd ln patlents 
with juvenile or inauU.n deficient type. of diabetes (87). 
Evidently, phenethylbiguanide does not require that functional 
pancreatic tissue be present. This fact excludes the possibility 
that it acts by st1mulatingthe beta cells to produce more in-
sulin as bas be. proposed for tolbutamide. 
It bas been oba.rved. however, tbat both of thes. compounds, 
wh_ added Ja BIEI, have a similar, inhibitory effect on the 
ineot."poration of leucine-alit lnto hapatie protein when used with 
the mict."os<'.IIles and cell sap isolated from normal rat l1ftr. 
Thill inhibition. Whioh baa also been ob.erved with chlorporpamide, 
is llnear over a conc8Dtrat1on r88le of 0 .. 10 lIM. Simllar 
con.dtration. of sodium chloride have shown that this 1Dhibltion 
cartftotbe .lIcribed simply to an lnC1:ea.e 1n 10nic strength or 
an incre.se 1n the aonGefttratlon of sod1UDl ion... TM. Ja n~l'g 
.ffect is important 1ft that it "pr •• ants a direct effect of the 
compounds. independent of their pos.ible .ffeots on insulin pro-
duction or other control aeohani... Wb._ the experiments were 
repttated using the eell-s.p and mlcrosomes from allOX4ft-dlabetio 
rata t the ent1"8 level of incorporation was so low that it waa 
diffioult to detemine whetber a aigrd.flaMt inhibiti .. occurred. 
1 t was certain, however t that In nO ca.e did the campounds stim-
ulate protein bioaynthe.is as ali.&bt be deatH<! in a compound used 
to treat diabetes mellitus. 
A mea8u,,_ant o.f the .ff.cte of the ccapounda on both 
.oluble and .1fto ... l bound pncet.ashGwed that 1ftoorpor:atiOD 
was depreaHd equally i.ft both fr:acrclona. 1ad1oatlna tbat both 
the tOlbutamide ad phelet'bJ'l.,ipaa1d. in<luead 1nb1bltlon 
000Uft'ed before thepnc.la w. nl ... ect frGal the I1.bo ... i ••• 
they dld DOC .ffect the ~.l .... atep 1n tbe blo..,atbetlc paCbway. 
Othn' u.ped.lDat.. ln which the leuet.a .. c14 wa_ oharsed by 
pn.1Douba.loa vt..h the cell "p, 5.ftc11eat. tbat tbe t.DhlbitlOft 
la both ••••• ocrfl'UZ1:ed afe_ tbe ' .... cl-. of .be _lao acyl-
•• IM .. ,la. In other WOI'd •• 'boCh t.1IN.-s.de aa4 pheeebyl. 
blauaald., added Ja .'D. lahlblt tbe lD~Ct._ of l_ala •• 
014 lato hepa'le p~ot.ll'l ......... at the 1 .... 1 of lbe .1. ...... . 
Tbl. 1. DO' to sa,. ~t tbey h~ a.. I.. pnci.ely lbe .... 
........ for: ltd.. i. a ....,. a_pla .eque .. of l'8&eCt.oaa. One 
eOllp«m4 alp' .. us. d1saa,peaatt.oa of I. riMa ... vht.l. Che 
other: alp- aff_ the annen1_ "etweea tbe aatao AflYl •• -RNA's 
aDd tbe t.,late. 11 ...... 1 .... 'tHMrh ... ,. an .... '0 aft at 
appl"OJd.aa'e1,.. ebe ... polDt 1ft t.ahl.bielaa the .Ira YJ.In biosyn-
theai. of hepalic proeeln. 
A .... 41 .en. •• of exped.Mllt ••• .. wi ... 1a ¥hleh the 
a..,.e ..... lnjeoted lnto laCaoc ard .. al.. The l1fta w" ehell 
~ ..... aft_ a period of tllD. aa4 lbe ald,U.cy of culr: .l ... 
•••• CO laeorponc. 1~a14 lato p"'eln wa. _.pand with 
that of .1 ...... ded.ve4 f..- tM 11'N1:8 of CIOD .... 1 anlmal. 
lDjecn:ed wltll saU.n.. Wb.a lln ..... t •• wen •• 1oy*,. lc wa. 
appaNltc tbat a .I.nale lIlj •• Cl_ of colbut_ide (0.3S .ill1. 
moles) or of phene~hylblguanide (0.10 mill! moles) resulted in a 
decreased abil1~y of the liver micros~ •• to incorporate leucine-
C14 into protein in yitIo. Th ••• results indicated that the 
inhibitory effect of the agent it.elf was greater than any stim. 
ulation it mi&"1.t produce by a secondary effect (8$. inereased 
production of insulin). 
When animals were injected. daily for a period of time (lor 
2 week.) with the agents (tolbutamide lnjeetion 0.1 m mole per 
day; phenethyl"igu4l\ide injection 0.02 m mole per day). there 
was no appreciable effect on the ."111ty of their livers to 
14 incorporate leueine-C into protein in !iSEo aa compared with 
control ard.mAlls giv.n 1Djections of .altn.. It might be .sfJUDted 
that under these oonditions tolbutamide would enhance leucine 
lncorporatlae into protein by virtue of increased insulin pre-
duction. but such was not: found to be the ease. !v1dently the 
inblbitory etfeet of the tolbutamide was sufficient to otfset 
the ettMulatioo produced by increased insulin production. 
A senes of cross-over exptriments was perfomed 1a which 
the microsome. from laline-injected animals were incubated with 
eall sap frem tolbueamide injected animala. etc. thea. r.sults 
showed an 1nhlbt.tion by st.tber agent wben the cell sap from an 
animal treaeed vien the agent was used I!U1d no lnh1bleion when 
only the microsomes trom. treated animals were employed. The.e 
results indieate that been tolbutamide and phenethylbiguanlde 
are located in the soluble call sap and are not bound apprecd.ably 
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to the microsomel. When the eell sap from an animal whieb was 
previously injected with an oral hypoglycemie &,ent is added to 
the 1n !&t[O system. it is essentially the same a8 adding a 
dilute solution of the alent and an inhibition of incorporation 
is observed. 
The results of thi. investi&ation. then. demonstrate a num-
ber of similariti •• between the effeets of tolbutamide and pheD-
ethylbiguanlde on protein biosynthesis. Both oompounds inhibit 
the incorporation of leucine.C14 into liver protein when added 
in n'a- In both ea •• s the dear •• of inhibition is of the sam. 
ma~nitud. and i. directly proportional to the concentration of 
agent added. this inhibition occur. somewhere at the microsomal 
site for both asents. indieatin, Similar, thoua,h not lUtc€,ssarlly 
the same. meehani._ of action. Purther, an acute larse JJa .x1:r.2 
injection of either compOWld results in an impaired ability of 
the animal's liver to incorporate leueine .. C14 into prot.in in 
nfEa. This An %l.x2 lmpab:ment is found in the cell sap of the 
injected animal probably due to the solubility of both compounds 
in aqueous solution. Neither tolbutamide nor phenethy1blauanlde 
appear. to bind to the microsam.s to any extent. 
Thes. similarities are unusual in that the two agents 
pos.... different mecnanisms of action in regard to their effects 
on carbohydrate metaboU.am. This only serves to emphaaize the 
fact that their effect on protein metabolism 18 not a secondary 
phenaa.non dependent upon the effect on carbohydrat ••• 
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The physioloslcal and clinical interpretations of these 
results are not conclusive. but illdieate tz.."s"'e thee. agent. do 
not control the imbalance in protein metabali.8m assoeiated With 
diabetes as well as insulin does. ~~enever an effeet of insulin 
em proteill metabolism has been ob.erved it has been one of In-
creasing protein biosynthesis rathe~ than of illhibiting the 
process. That the oral hypoglycemic agellta can inhibit protein 
biosynthesis S&tlmS clear; whether: this lnhibition oeeurs to any 
extent in the adult dlabetic on a daily maint'enance dose of tol-
butamide or phenethylbi~uanid. falls t4ithin the realm of elinieal 
investigation. There are only a t4'i scattered elinieal report's 
in the literature on this subject at the present time. Mutln! 
(80) noted that there was no ch4ns,e in serum protein comp"sltion 
of 101 diabetic patients after successful lone term tr •• ~.nt 
with tolbutamide. Dei~eutter (23) demonstrated that following the 
administration of tolbutamide to normGl subjects. there was a 
decrease in lerum amino acids eomparable to that tollowin! the 
administration of insulin. 
On the other hand. Green_er!, and coworkers (34), approaching 
the problem of the efficaey of the oral hypoglycemic agenta from 
a clinical point of view, have arrived at conclusions substant-
ially in agreement with those presented here. They observed a 
alsnificant: ris8 in beta-lipoprotein levels in patients sYitchad 
from insulin to tolbutamide therapy. Thus it: appears that there 
are at lea.st two areas in the diabetic condi1:ion. protein and 
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11pol'!.'Otetn "'8tabol1a., when the oral bypo~lyeemtc asent. fall 
1:0 _en ~:'d"mtJm ftOl'ttrol. This tndtee.t •• a need tor: further 
"""1"01\ on the .ffecta of the 01'.1 bypo@;lyeemle as;enta Oft ot:lwl" 
.epee1:. of tll.bette m8tabolt., web •• U.pld and Duelei.e acid 
••• aboll.lIII. 
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TABLE XXII 
STRUCTURES or ORAL HYPOOLYCEMI C AGENTS 
Tolbutamide 
c=c 
/ " 01 - C C - S02NHCONH(C~ )2CH, 
~ ~ C-C 
Chlorpropamide 
C=c 
/ " C~ ,C -(C~)2 NH~HnN~ 
C-C 58 "" 
Pbenethylbisuanlde 
... 140. 
TABLE XXIII 
EPFIc;..91 or WA§H1ftGS I 
All the wa.hinss of on. protein fraction were saved. A 
1.0 ml. aliquot of .ach washiDI was plated and counted. 
WASHING C.P.M. Volume of Wash 
(ml.) 
tJ 
Supematant 27,500 6.2 
TCA 4,700 S.O 
EtbAllol 1 346 S.O 
EthAnol 2 149 S.O 
Ethanol 3 29 S.O 
Acetone 1 17 S.O 
Acetone 2 14 S.O 
Acetone 3 18 S.O 
After the third ethanol wash, • bacqround COUftt: is 
obtained. Tbis indicat.s that the va.hinSs employed 
were sufficient to remove nonincorporated radioaotivity. 
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TABLE XXIV 
m1CACX OF WASHlNGS II 
The flnal aeeton. wash fram each of 11 flasks was saved. 
1.0 mI. of this was plated out and counted to check the 
efficiency of the vashin ••• 
SAMPLE NO. C.P.K. 
1 1.~ 
2 13 
3 16 
4 13 
S 12 
6 11 
1 11 
8 14 
9 14 
10 12 
11 13 
• 
The fact that a backr;round COUDt is obt.ined in all 
c.... atte.ts to 1':1'-,« l!9t'flclency of the washins pro-
cedure 1n reMovin& nonlncorporated radio.ctivity. 
TABLE XXV 
DATA ON ALLOXANllED RATS 
Rat 4/25 4/26/66 4/27/66 4/27/66 4/28/66 4/28/66 4/28/66 4/28/66 
Ro. vat. uruulry UJ:inary urlnary wit. urinary urinary b loGe! 
1 
2 
3 
4 
S 
6 
7 
8 
9 
10 
11 
12 
glucos. 81uco •• ketGft.. 81UOO •• ketone. gluco •• 
157 + 
--
lIS + trace 
145 
-
+ 
-
108 + +-
IS9 trace 113 + 
- - -
150 
-
+ trace 116 + + 
145 + 
- -
119 + + 
146 + 114 + trace 
- -
152 
-
+ 
-
118 + trace 
ISO 
-
+ trace Dead x x 
IS4 + 119 + 
- - -
IS4 
-
+ .. 131 + 
-
159 + trace 132 + 
- -
152 + 119 + 
- - -
Animals war. injected 'tilth 20 ma/K,. alloxan at noon 
on 4/26/66 
1160 
1400 
1212 
1860 
2480 
736 
1472 
x 
1128 
952 
1152 
2456 
TABLE XXVI 
9Q1POSITIO! 9l UI').ABELED AMltlOACID SOLUtION 
AMINO ACID H.W. q/SOO ml. 
Dt - Ala 89.1 25.4 
L ... Ar:g. ~no. 7 30.2 
DL ... Asp 133.1 38.0 
L ... CyS 115.6 2S.1 
L ... CySS 240.3 34.4 
L ... Glu 147.0 21.0 
Gly 15.1 10.7 
L ... His 209.6 30.0 
DL ... 11eu 131.2 37.6 
L ... Ly. 182.7 26.1 
DL ... Met 149.2 42.6 
DL ... Phe 165.2 47.2 
L ... Pro 115.1 16.5 
DL ... Sar: 10S.1 30.0 
DL ... Tbr 119.1 34.0 
L ... Try 204.2 29.2 
L ... Tyr 181.2 2S.9 
DL ... Val 117.1 33.4 
L ... Pro ... OR 131.1 18.7 
The .olution •• so d •• i8lled that there would be .043 u mol •• 
of each L-amino acid per 0.3 ml.1af .olution. Thi. amount. to 
10 tlrae. the _ount of leueine-C added per f l •• k. 
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ixPH1aDS ~3A: Iff.ot 1it lbI C __ tr.tilP s! Pb •• tllYA!!,· 
1Ulp14 ... .IIa IDlOQ9I',,1111.t11·!"'f..II-gI4 J.atI §eRlt's lus,y! 
.If. 1,.,1 1ft,. 
Thi. experiment was pact.ned .fter _perlalDt 13 (P. 74) 
and va. de.iped to wrif)' ,he .ffeet of t_ ill nero addition 
of pbeftethylbt.guanid. on tbe lDeo~oration of leuoiDe-Cl4 into 
hepatic prot.lll. Mlc ........ and eell •• p fraa nomal anlul. 
wen incubatecl with vaX")'llll _CNDt. of phela.thylbt.panld •• 
'lbe hault ..... lD 1'1...- XII1 support tboa. o.tained 
..... ll.r 1ft Ft.au" Xl (P. 75). It 1 ..... tbat pbeMthylbt.panld. 
iDhlblt. the lA .. ,..atiOll of leu.et.at-CI4 lDto _patio prot.in 
wha aclded .Ia n5D. nt. •• ~daeDt verifl •• the ob ........ tion 
,bat tbe d'ane of t.nhl.bitlO1l 1. clinocl" p ... oportional t. the 
_ouat of aaent .deled oYe.. the ran.. of 0 • 10 11M. Thu. the be-
haVior of pb.eD.tbylblauanld. 111 thi. ."et. 1. wry .imilar to 
that of tolbut.ld. and ohloJ:p ... opaaid. (a ..... 1D rlp .... Xl). 
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Figure XlII 
The Effect of the 111 ntES! Addition of Phtmethylbiguanide on 
the Incorporation of Leucine.C14 into the Protein of Llver 
Micro.ome. from Normal Rats. (Confirmatory Experiment). 
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